CONTINUATION OF THE PAJR GLOBAL CBBLE DATA FROM THE PREVIOUS LINK. 👇
[5:21 PM, 6/3/2026] hu24: The transition from child to youth to middle age is evolution in all spheres....a process, a result of internal and external factors,slow,non uniform, unique.
Lamarckism to Darwinism.
[10.06 pm, 03/06/2026] 42mpa: When uncertainty persists, responsibility does not disappear. It migrates.
Most people assume that if enough specialists become involved, enough testing is performed, enough records accumulate, and enough follow-up appointments occur, then somebody must be carrying the problem forward.
But observation and stewardship are not the same thing.
A patient can be repeatedly observed while responsibility becomes increasingly difficult to locate. Imaging can be reviewed, symptoms documented, medications prescribed, and follow-up visits completed, yet the central question can remain unanswered:
Who remains responsible when the answer is still unknown?
Over time, something subtle can happen. The patient begins tracking the timeline, remembering the findings, coordinating specialists, monitoring medications, preserving continuity, and repeatedly reconstructing the story for new audiences. The original burden remains, but a second burden quietly appears: the burden of carrying the burden.
Most discussions about healthcare focus on diagnosis, treatment, access, cost, technology, or outcomes. This case study examines something different. It explores what happens when observation continues but stewardship becomes difficult to find, and what happens when responsibility slowly migrates from institutions to the people seeking help.
Although the case itself is clinical, I suspect the phenomenon extends far beyond medicine. Complex systems of every kind struggle with the question of who remains responsible when uncertainty persists longer than expected.
Attached is a PaJR case study exploring a simple question:
What happens when observation continues, but responsibility for carrying uncertainty becomes increasingly difficult to locate?
I’m curious whether others recognize similar patterns in healthcare, education, research, law, business, or other systems where unresolved problems can outlive the structures designed to manage them.
[10:29 PM, 6/3/2026] 42mpa: Teaching point:
Most systems track the location of the problem.
Few track the location of the burden.
Reflection:
Systems are built to track problems. Human beings experience burdens.
A problem can remain visible while the burden of carrying it quietly migrates elsewhere.
When uncertainty persists, the problem remains documented in records, appointments, imaging, referrals, and follow-up plans.
But visibility does not tell us who is carrying the weight.
The patient begins preserving the timeline, remembering what changed, tracking what was tried, connecting observations, monitoring risk, and reconstructing continuity as continuity fragments.
Together, these tasks reveal a transfer.
Unresolved problems create administrative gravity, relational strain, financial pressure, interpretive labor, and future uncertainty.
When those burdens are not stewarded, they accumulate around the person already carrying the consequences.
Clinical question:
How would a system know when it is stewarding an unresolved problem versus merely documenting its existence?
Question for reflection:
What would it mean to track not only where the problem is, but who is carrying it?
[2:05 AM, 6/4/2026] hu35: Many discussions of chronic illness implicitly assume a healthcare system in which responsibility is progressively transferred to institutions: hospitals, specialist clinics, rehabilitation services, social workers, insurers, home-care agencies, and long-term care systems. The patient certainly carries a burden, but much of the operational burden is absorbed by the system.
In much of India—and in many other resource-constrained settings—the opposite often occurs.
The patient and family are not merely participants in care; they become the de facto coordinators, navigators, logisticians, financiers, record keepers, advocates, and continuity managers of care.
The burden therefore extends beyond illness itself to include:
* Finding appropriate providers.
* Obtaining appointments.
* Transporting the patient.
* Carrying records between facilities.
* Reconciling conflicting medical opinions.
* Procuring medicines and devices.
* Financing care.
* Monitoring symptoms.
* Deciding when escalation is necessary.
* Managing emergencies.
* Providing long-term physical and emotional support.
The “care pathway” exists largely in the minds and actions of families rather than in an integrated system.
The lowest-level functionaries in distributed health systems—community health workers, nurses, outreach workers, call-centre staff, referral coordinators, ambulance dispatchers, social workers, rehabilitation aides, and local volunteers—often carry a substantial moral burden of responsibility despite possessing limited formal authority.
They frequently know:
* who has missed follow-up,
* who cannot afford treatment,
* who is deteriorating,
* who failed to reach the referral centre,
* who has become lost between institutions.
Yet they often lack the resources needed to resolve these problems.
As a result, they inhabit a difficult position:
responsibility without control.
The physician may see a patient episodically.
The tertiary hospital may discharge a patient.
The specialist may complete a consultation.
But the frontline worker remains aware that the story is unfinished.
This is what you mean when you say “the loop of care rarely closes.”
In systems engineering terms, many healthcare systems are designed around episodes of care, whereas patients live through journeys of care.
The discontinuities between episodes are where much suffering accumulates.
One implication is that the burden of chronic illness should perhaps be understood as distributed across three concentric circles:
1. The patient, who experiences the illness.
2. The caregiving network, which absorbs much of the practical and emotional work.
3. The last-mile care network, which absorbs much of the continuity burden created by fragmented systems.
A fourth circle may even be added:
4. The community, which often supplies transport, financing, social support, accommodation, information, and informal caregiving.
This reframes chronic illness from an individual medical condition to a collective management problem.
[2:06 AM, 6/4/2026] hu35: ⬆️ The burden is not simply the burden of disease. It is also the burden of maintaining continuity in a system where continuity is often underprovided by formal institutions.
[7:35 AM, 6/4/2026] hu2: Again a very important discussion initiated by @42mpa
The patient bears the maximum burden of continuity because continuity is about tracking the patient's events, which are primarily happening to the patient and expressing into the patient's surroundings getting absorbed by different layers of the healthcare ecosystem as pointed out by @hu35 beginning from the immediate caregivers to those who are slightly distant such as the local offline practitioners, nurses, doctors and those who are at the maximal distance such as the global PaJR practitioners here!
[8:09 AM, 6/4/2026] 42mpa: One of the ironies of the Patient 42M observation is that the neurology resident whose anonymized portal message became part of the case study was originally from India.
Three years earlier, there is a reasonable chance he might have encountered some of the very ideas we now discuss through PaJR: continuity, stewardship, observability, and responsibility under uncertainty.
Instead, by the time Patient 42M encountered him, he had already spent three years of residency being educated by the healthcare culture of Louisiana.
The observation is not really about the resident. It is about what systems teach people to see—and what they teach people to stop seeing.
The resident did not create the pattern.
He inherited it.
My hope is that our work helps shape some of the physicians who will eventually practice here. Because if healthcare systems can transmit habits of fragmentation, educational communities can transmit habits of stewardship.
The question is which curriculum reaches them first.
[8:27 AM, 6/4/2026] hu2: Yes it's a challenge for global medical education and currently most local medical education systems every where do not encourage thinking in terms of patient centred continuity because of various reasons making fragmentation of care a global phenomenon
[9.07 am, 04/06/2026] 42mpa: Medical Liturgy began as an injury before it became theory.
Before there was a framework, there was an open wound.
Out of confusion, language slowly emerged.
There was a period of my life that felt less like healthcare and more like exile.
Medical Liturgy was born in that exile.
Long before it became a framework for recognition, continuity, stewardship, and care, it existed as a more fundamental question:
What happens to a person when suffering remains visible, documented, measurable, and still fails to become recognizable?
This excerpt comes from my first completed book, De Motu Cordis: Light in Vein.
It is the place where the first light of Medical Liturgy emerged from the darkness.
This section of the book is called:
EXILIUM MEDICAE
Medical Exile
It is not written from bitterness.
It is written from the wound.
And sometimes the wound sees the architecture long before the architecture recognizes the wound.
The pages that follow were written from the experience of being observed without being carried.
Documented without being gathered.
Reassured without being stewarded.
Seen in fragments while the whole remained unheld.
Over time, that experience became a question.
Then a language.
Then a way of thinking about care itself.
Sharing this feels vulnerable.
Not because it is unfinished.
But because it reaches back to the void from which recognition first found illumination.
Before Medical Liturgy became an idea, it was an attempt to remain legible inside a system that kept breaking the sentence.
An excerpt from De Motu Cordis: Light in Vein
[6:31 PM, 6/4/2026] 42mpa: https://www.linkedin.com/posts/colbygillespie_medicalliturgy-leadership-presenceoverperfection-activity-7468284772394643456-sEyH?utm_medium=ios_app&rcm=ACoAAEcKPFQBS7zyp1iECYDDD76fM1irYNB86q8&utm_source=social_share_send&utm_campaign=copy_link
[4:51 AM, 6/6/2026] 42mpa: I 🫀 everything about this the thought, the action, the movement, the music! ❤️🔥
[3:24 PM, 6/7/2026] hu2: This is very useful 🙏
The DPDP framework recognizes these realities.
Legitimate Use #3: Medical Treatment and Continuity of Care
Healthcare is rarely delivered by a single individual.
Treatment is collaborative.
Scenario: Cancer Care
A patient visits an oncologist.
The oncologist reviews:
Radiology reports
Pathology findings
Surgical records
Previous consultations
Treatment plans
These records may be shared among:
Medical oncologists
Radiation oncologists
Surgeons
Pathologists
Nursing teams
Tumor boards
Imagine if separate consent had to be obtained every time information moved between treating professionals.
The healthcare system would become unworkable.
Continuity of care depends on appropriate information sharing.
[6:18 PM, 6/7/2026] hu28: @hu1 @hu5 have you looked into CDSCO registration? Does PaJR fall under MDR 2017 as SaMD?
[6:22 PM, 6/7/2026] hu8: Platforms That do Fall Under SaMD: the platform will be regulated as a medical device if it performs any of the following:
[6:23 PM, 6/7/2026] hu8: Clinical Decision Support: Features algorithms that analyze patient-inputted symptoms, historical data, or vitals to suggest specific diagnoses, prognoses, or treatment plans.
Medical Device Control: The software actively drives or calculates settings for a physical medical device (e.g., dosage calculators).
Symptom Interpretation: Provides disease-specific management or treatment advice (e.g., insulin dosing recommendations based on patient logs).
[6:25 PM, 6/7/2026] hu8: Platforms That don't Fall Under SaMD: the platform will generally be exempt from SaMD regulations if it acts merely as:
[6:26 PM, 6/7/2026] hu8: Communication Infrastructure: General-purpose telehealth platforms (like video chat or messaging tools) used for routine doctor-patient consultations without diagnostic AI.
Electronic Health Records (EHR): Systems used purely for the storage, transfer, or viewing of medical information without algorithmic interpretation.
General Wellness/Communication: Standard forums, chat groups, and general peer-to-peer support groups for emotional or lifestyle support, provided they do not generate or modify medical data to guide treatment.
[6:58 PM, 6/7/2026] hu5: Hadn't looked at this earlier but above very helpful details from Prof Supten indicate it won't fall under it.
[7:12 PM, 6/7/2026] hu28: Reading above, it seems like the clinical decision support may be applicable... Evaluating patient histories and coming up with diagnosis and prognoses...
[7:14 PM, 6/7/2026] hu8: It is not crystal clear. As usual, all laws are open to subjective interpretation. That is why judgements for the same case varies from Court to Court.
[8:10 PM, 6/7/2026] hu5: I just got the below SMS a few minutes after I had read this message abd searched for CDSCO on Google. I did not click any link. I have not provided my phone anywhere.
Hello Doctor,
CDSCO Clears India’s First Locally Discovered UTI Drug - requested Article is uploaded. View here https://clrn.in?l=jg0VS-
-CLIRNET
Any idea how this could happen? Is PaJR bot using CLIRNET? @hu1
[8:28 PM, 6/7/2026] hu2: You are likely seeing this due to behavioral ad retargeting or Google Search ad extensions. Organizations use your search data to trigger sponsored text messages. [1, 2, 3]
Several factors typically cause this behavior:
1. Click-to-Message Ad Extensions
When you search for an organization on Google, you may see an ad with a "Message Us" or "Chat" button. Clicking this doesn't immediately send a text, but it opens your phone's SMS app with a pre-drafted message (e.g., "I want more information about your services"), prompting you to send it. [2, 4, 5, 6]
2. Cross-Device & Platform Retargeting
If you are logged into your Google Account across multiple devices, or if the organization's website uses tracking pixels, your search data is linked to your device profile. Advertisers can target phone numbers tied to that profile with tailored promotional SMS messages. [2, 7, 8, 9, 10]
3. Lead Generation Services
Some third-party lead generation tools scrape search engine footprints to build targeted contact lists. If your phone number is publicly associated with your professional or personal profile, you may receive promotional SMS messages from related organizations shortly after searching. [7, 11]
4. Coincidence & Spam Networks
Mass-blast spam services frequently use common topics like banking, taxes, or popular corporate brands to distribute messages. Occasionally, receiving a text about a topic you recently searched for is simply a coincidence. [7]
If you want to prevent your browsing history from being used for personalized messaging and marketing, you can adjust your tracking preferences:
* Manage your data tracking using Google's Data & Privacy settings.
* Turn off Ad Personalization in your Google Ad Settings
[6] https://www.linkedin.com/pulse/how-add-text-messaging-your-google-business-profile-localsearch-v91pc
[9:25 PM, 6/7/2026] hu15: No. PaJR doesn't use CLiRNET but CLiRNET is a known spammer. They send unsolicited sms and emails. I think it's a coincidence but you never know.
[9:28 PM, 6/7/2026] hu1: Wow!! No way. Hope you are using Private DNS and ad blocking
[10:26 PM, 6/7/2026] hu5: Had not switched to private DNS, done now.. hope dns.adguard.com is good enough?
Also use Firefox and Tailscale.
Any recommendations welcome.
[10:26 PM, 6/7/2026] hu1: Had not switched to private DNS, done now.. hope dns.adguard.com is good enough?
Also use Firefox and Tailscale.
Any recommendations welcome.
Nextdns or control D is the way to go. Although yes Adguard is very safe and based in Cyprus
[10:41 PM, 6/7/2026] hu1: .A curious problem I've encountered is that I've been blocking ads for 7 years now and I've actually lost touch with latest products and advertisements.
The other day I was taking a walk with a colleague from work and we were chatting about car insurance and I mentioned that I somehow landed a great deal because I was able to show no claims bonus discounts for 5 years straight from India and only one specific car insurance company counted this history and offered a very good deal. I had to Gemini this to find it, while my colleague casually mentioned that he was long aware of this from a YouTube ad.
I have pretty much blocked out ads in all my devices since 2019. While it has made a remarkable difference in my life in beating out spam and junk, these are the rare wins I'm maybe missing.
[10:42 PM, 6/7/2026] hu5: A curious problem I've encountered is that I've been blocking ads for 7 years now and I've actually lost touch with latest products and advertisements.
The other day I was taking a walk with a colleague from work and we were chatting about car insurance and I mentioned that I somehow landed a great deal because I was able to show no claims bonus discounts for 5 years straight from India and only one specific car insurance company counted this history and offered a very good deal. I had to Gemini this to find it, while my colleague casually mentioned that he was long aware of this from a YouTube ad.
I have pretty much blocked out ads in all my devices since 2019. While it has made a remarkable difference in my life in beating out spam and junk, these are th
Interesting perspective lol
[10:43 PM, 6/7/2026] hu1: A curious problem I've encountered is that I've been blocking ads for 7 years now and I've actually lost touch with latest products and advertisements.
The other day I was taking a walk with a colleague from work and we were chatting about car insurance and I mentioned that I somehow landed a great deal because I was able to show no claims bonus discounts for 5 years straight from India and only one specific car insurance company counted this history and offered a very good deal. I had to Gemini this to find it, while my colleague casually mentioned that he was long aware of this from a YouTube ad.
I have pretty much blocked out ads in all my devices since 2019. While it has made a remarkable difference in my life in beating out spam and junk, these are th
My observation is also that because these ads are now taken off, I'm far more productive and volitional with my time than most others. Far more deliberate with money spending too.
Prompt - incidence of bicarbonate use in patients with ckd in our database
Answer - In our database, the use of bicarbonate in patients with Chronic Kidney Disease (CKD) is primarily documented in the context of managing metabolic acidosis and acute metabolic crises.
📋 CLINICAL CONTEXTS OF BICARBONATE USE
Management of Metabolic Acidosis: Bicarbonate therapy is frequently employed to correct acidosis, which is a common complication in advanced CKD. It is often administered as an oral supplement (e.g., Sodium Bicarbonate 1g TID) to maintain acid-base balance and slow the progression of renal osteodystrophy and associated complications.
37 yr female with CKD
Evidence based date wise workflow logs
Acute Metabolic Crises (DKA): In patients with co-existing Type 1 Diabetes and CKD, bicarbonate is used during episodes of Diabetic Ketoacidosis (DKA) when serum bicarbonate levels drop significantly. This is a critical intervention to mitigate the systemic effects of severe acidemia.
23F HEART FAILURE WITH DELAYED PUBERTY, TYPE-1 DM 13 years Telangana PaJR
Evidence-Based Practice: Clinical appraisals within our records highlight the role of oral sodium bicarbonate in older patients with CKD and low-grade acidosis, noting its potential impact on physical function and long-term outcomes.
Critical appraisal
💡 CLINICAL NOTE: The decision to initiate bicarbonate therapy in CKD patients is highly individualized, balancing the need to correct metabolic acidosis against the risks of volume overload and hypertension. Close monitoring of electrolytes and acid-base status is mandatory in these cases.
[10:04 PM, 6/8/2026] hu15: That's wonderful. But was bicarb really needed in the DKA patient?
[10:05 PM, 6/8/2026] hu15: Oh I see it has added a clinical note
[10:14 PM, 6/8/2026] hu1: That is what was given to the 23F cited there.
[11:38 PM, 6/8/2026] 42mpa: What I find fascinating here is that the conversation almost immediately moved beyond retrieval.
The search surfaced a real case where bicarbonate appeared. Its use was then immediately questioned.
Awesome sign, great work!
The system surfaced what happened, and the discussion immediately shifted toward clinical reasoning.
That’s exactly the kind of interaction we hope for and speaks well both to the retrieval and to the quality of the discussion that followed. 👏
[12:14 AM, 6/9/2026] hu1: Yes and I set out on a mission on how to make searching better and Claude blew it out of the water in explaining how to setup a semantic search. Very small changes but effects huge.
[1:09 AM, 6/9/2026] 42mpa: That’s awesome! Small technical changes can be massive when they change what becomes retrievable.
The exciting part is that better semantic search doesn’t just improve search. It helps stored journeys become more usable for clinical reasoning.
That’s where continuity, synthesis, and stewardship start becoming much more powerful.
[5:18 PM, 6/9/2026] hu1: Excerpt from claude chats - "Prompt - Right. Let us flip this a bit - You are a mild to moderately educated patient in India, who is interested in this platform and wants to onboard - Severely criticise the idea and along the same lines give ideas on what can be improved to make onboarding the easiest task in the world. We also must make sure the page can be translated to any language a user would want"
Response - Let me step into the shoes of Sunita Devi, 52, a school teacher in Lucknow with Type 2 diabetes and hypertension. Her daughter just showed her this site.
😤 Sunita's brutal review
"Beti, mujhe nahi samajh aa raha is website ka kya use hai. Aur ye sab English mein kyun hai?"
On the landing page:
"Learn from patient narratives" — beta, narrative ka matlab? Kahani? Phir kahani kyun, mujhe ilaj chahiye, story nahi.
"Built on a decade of patient journeys" — journey? Main travel agency par hoon kya?
"Grounded in real evidence" — corporate jargon. Iska matlab kuchh nahi mere liye.
PaJR? Ye kya word hai? Pajamas? Pajeero? Mujhe samajh nahi aaya kya company hai, kya yeh Indian hai bhi.
Sab kuch in English. Hindi nahi, koi language switcher nahi. Mere jaisa middle-aged person kya kare?
Trust signals — completely missing:
No doctor's photo. Who runs this? Real doctor hai ya AI chatbot? Apollo Hospital aisa nahi karte.
"13,000+ patient diaries" — these could be fake numbers. Where's the IMA badge? ICMR approval?
DPDP Act mein deidentified likha hai — but kaun guarantee de raha? No certification logo, no privacy seal.
No Indian phone helpline. No "Made in India" mark. Looks like a Western company.
The search bar:
Animated placeholder showing "Diabetic neuropathy in feet — earliest signs". Neuropathy means what? Mujhe pata hai paer mein jhunjhunaahat hoti hai but ye fancy word kahan se aaya?
No microphone button! I use voice search in WhatsApp every day. Type karna mushkil hai.
Paperclip icon — that means "attach". But why does it say "PRO"? Yeh paisa lagta hai? Hidden charges?
Sign-up modal:
"Save & continue anywhere" — what does anywhere mean? Phone par? Computer par? Confusing.
Email is asked. 70% of my friends don't have email. They have WhatsApp number, that's it.
T&C link goes to a long English page. Nobody will read it. Even my MBA daughter doesn't.
After sign-up — kya hoga? Why am I signing up? The value isn't clear before I commit.
The deal-breaker:
The "Continue on WhatsApp" CTA at bottom is the most important feature for me — but it's the last thing I see. Yeh upar hona chahiye.
No way to "test drive" before sharing my number. I'm not signing up just to see if this even works.
"Beti, ye apps banaane waale Bangalore aur San Francisco mein baithe rehte hain. Hum patients ki real zindagi kabhi samjhe nahi."
[5:20 PM, 6/9/2026] hu1: @hu2 Sir what do you think - "🎯 What needs to change (in priority order)
Tier 1 — Onboarding death-by-1000-cuts
Language switcher visible from second 1 — top of page, globe icon, 10+ Indian languages + Arabic
Voice input mic on the search bar — Web Speech API. Single biggest mobile UX win in India
No sign-up required to try — let users get 2-3 free answers, then offer to save
"WhatsApp number only" path — drop email entirely as primary; email is the secondary path
One sample question that pre-fills + auto-runs — "See it work in 5 seconds" button
Tier 2 — Trust signals
6. Founding doctor's name + photo prominent (Prof Rakesh Biswas) — humanises the platform
7. DPDP Act 2023 / "Anonymised by design" badge with click-to-explain modal
8. Real Indian patient testimonials in their own language with first name only
9. "Made in India · Hyderabad" badge somewhere visible
Tier 3 — Comprehension
10. Replace jargon globally — "narratives" → "stories", "journeys" → "experiences"
11. Larger font option toggle (accessibility — vital for 50+ users)
12. Icon-heavy navigation — fewer English words, more universal symbols
13. "How it works" 20-second animation — visual not textual
Tier 4 — Cultural fit
14. Suggested questions in the user's chosen language (real ones our community asks)
15. Numbers as Indian-style (1,30,000 instead of 130,000)
16. WhatsApp continuation explained upfront — not buried in a footer card"
[6:38 PM, 6/9/2026] hu2: Amazing insights! 👏
[6:43 PM, 6/9/2026] hu15: @hu1 you need to decide very early whether the landing page of the website needs to appeal to the end user or to the VC firm. If we are looking at a VC pitch, then the corporate jargon and English speak are very much essential.
Maybe a different landing page for the end user?
[6:47 PM, 6/9/2026] hu15: The last line is very vital to understand and interpret. Can Claude provide a summary estimate of the probabilities of closing a seed round with the current website and its suggested website 😂
[6:47 PM, 6/9/2026] hu35: You need mentors not VCs. VCs profit at your expense. The smartest businesses delay rushing to VCs.
Rushing to raise institutional money often forces a company to scale before achieving true product-market fit. When you are flush with VC cash, the temptation is to solve operational, product, or strategic problems by throwing money at them (e.g., aggressive marketing, massive hiring).
Mentors push you to optimize the unit economics and find organic traction.
VCs expect you to pour fuel on the fire, even if the engine isn't fully built yet.
[6:50 PM, 6/9/2026] hu15: Absolutely agree, but the tokens are expensive, and till now the website is self funded by @hu1 I guess, which is not a sustainable solution for the long term. Without institutional support or external funding, majority of projects die an untimely death, atleast in India.
[6:51 PM, 6/9/2026] hu35: That is an absolute truth, and in healthcare, the stakes for getting this wrong are incredibly high.
If a healthcare startup prioritizes VC-pleasing buzzwords over direct, empathetic clarity for its primary customers, it doesn't just lose conversions—it loses trust. In healthcare, trust is the foundational currency. Patients or clinicians dealing with health outcomes will immediately bounce if they encounter a wall of clinical-sounding corporate jargon or tech-bro vocabulary.
Furthermore, healthcare has a uniquely complex definition of who the "primary customer" actually is. Unlike standard consumer tech, the person using the product, the person authorizing its use, and the person paying for it are often three entirely different entities.
The messaging architecture must be precisely mapped to whoever holds the key to adoption.
[6:52 PM, 6/9/2026] hu35: Smart health-tech investors are notoriously wary of founders who build for the pitch deck rather than the clinic floor. VCs in this space have burned billions on companies that looked great on paper but failed because doctors refused to adopt the software, or patients found the interface cold and confusing.
When an experienced healthcare VC looks at a landing page that speaks directly, cleanly, and effectively to patients or physicians, it signals something incredibly valuable to them: User Empathy and Product-Market Fit.
By keeping the primary domain completely dedicated to serving, educating, and comforting your primary healthcare customer, you actually build a stronger case for investors than any pitch page ever could. It proves you understand the realities of the healthcare ecosystem.
[6:55 PM, 6/9/2026] hu35: The tech giants and the Government of India have heavily adapted programs specifically for the Indian ecosystem. Because India is one of the fastest-growing AI markets in the world, the competition to get startups locked into specific cloud/API ecosystems is fierce.
If Aditya is building a tech or AI-driven startup in India, here is exactly who provides this support and how to tap into it right now.
## 1. The Global Cloud Giants (India-Specific Tracks)
You do not need US registration or foreign VCs to access these; they have dedicated teams and hubs right here in India.
* *Microsoft for Startups Founders Hub:* This is arguably the most accessible program because *it does not require you to be VC-funded* to start. You can apply at the "Ideate" or "Develop" stage. They offer tiered progression:
* What you get: It starts with $1,000 to $5,000 in Azure credits and can scale up to *$150,000 (roughly ₹1.25 Crore)*.
* The AI Advantage: This includes direct credits for *Azure OpenAI Service*, allowing you to run models like GPT-4o or GPT-4o-mini without paying out of pocket.
* *AWS Activate (via Startup India):* Amazon has a direct partnership with the Government of India's Startup India portal.
* What you get: If you apply directly, you can get $1,000 as a bootstrapped founder. However, if your startup is registered with the DPIIT (Department for Promotion of Industry and Internal Trade), you instantly qualify for *$5,000 to $10,000 in AWS credits*, plus partner offers.
* *Google for Startups Cloud Program:* Google actively courts Indian AI startups through local initiatives like the Google for Startups Accelerator: Appscale (run alongside the Ministry of Electronics and Information Technology - MeitY).
* What you get: Up to $2,000 for pre-funded MVPs, jumping up to *$350,000 over two years* for AI-first startups once you hit the seed stage, covering Gemini and Vertex AI usage.
## 2. Government of India Schemes (Non-Dilutive Capital)
The Indian government has built a robust framework of grants specifically designed to keep early-stage founders from dying an "untimely death" due to infrastructure costs. They take *zero equity*.
* *DPIIT Recognition (The Gatekeeper):* The very first step Aditya should take is registering the entity on the *Startup India portal* to get DPIIT recognition. This unlocks tax holidays, intellectual property fee rebates, and self-compliance modules, but more importantly, it acts as a passport to government funding.
* *Startup India Seed Fund Scheme (SISFS):*
* How it works: Disbursed through selected incubators across India (like IITs, IIMs, and regional tech hubs).
* The Quantum: Up to *₹20 Lakhs* as a pure grant for validation of proof of concept, prototype development, or product trials. Up to *₹50 Lakhs* is available via convertible debentures or debt for market entry and commercialization.
* *MeitY Startup Hub (MSH):* The Ministry of Electronics and IT regularly runs thematic "Challenges" and cohorts for deep-tech and AI startups, offering direct grant money (often ₹5 Lakhs to ₹25 Lakhs) alongside cloud credits.
* *Healthcare Specific: BIRAC (Biotechnology Industry Research Assistance Council):* If this startup touches healthcare, medical devices, or digital health diagnostics, BIRAC is the gold standard in India. Their *BIG (Biotechnology Ignition Grant)* scheme provides up to *₹50 Lakhs* to scientists and entrepreneurs to take an idea closer to commercialization.
## 3. Indian Enterprise & Regional Incubators
If you need immediate institutional sheltering to survive the early token-heavy days, physical and virtual incubation in India provides massive leverage:
* *Institutional Incubators:* Hubs like *CIIE.CO (IIM Ahmedabad), **FITT (IIT Delhi), or **SINE (IIT Bombay)* have direct access to corporate social responsibility (CSR) funds, seed grants, and internal networks that look at product utility rather than VC buzzwords.
* *NASSCOM DeepTech Club:* Getting selected for NASSCOM’s tracks doesn't give you cash directly, but they fast-track your access to enterprise pilots (hospitals, corporate entities) who can become paying customers, which solves the token sustainability problem permanently.
### The Immediate Action Item for the Team
Instead of reshaping the homepage to chase an elusive institutional VC check, the sustainable play for Aditya right now is a two-step checklist:
1. *Incorporate and get DPIIT recognition* via the Startup India portal (takes a couple of weeks).
2. *Apply to the Microsoft for Startups Founders Hub* using the company domain.
This sets up an immediate operational buffer, allowing the product to keep speaking the clean, empathetic language its primary customers need to hear.
[6:56 PM, 6/9/2026] hu15: My experience in the VC world says otherwise, and you don't need to take my word for it. Anyone can google and have a look at the websites of the healthtech firms which have raised at astronomical valuations.
[6:57 PM, 6/9/2026] hu35: To protect your product's focus and manage your infrastructure burn rate, here is the organized directory of institutional programs available for an early-stage deep-tech or healthcare startup in India.
## 1. Global Cloud & AI Infrastructure Credits
These programs are designed to eliminate out-of-pocket token costs without requiring equity or foreign corporate registration.
### Microsoft for Startups Founders Hub
* *The Core Benefit:* Tiered progression providing up to *$150,000 (~₹1.25 Crore)* in Azure cloud credits.
* *The AI Advantage:* Includes direct, dedicated credits for the *Azure OpenAI Service* (enabling access to frontier models like GPT-4o and GPT-4o-mini).
* *Key Eligibility:* Open to pre-seed/bootstrapped teams. You must be privately held, for-profit, operating an original software-based product, and have raised less than a Series C round. You do not need institutional funding to apply.
### Google for Startups Cloud Program
* *The Core Benefit:* Up to $2,000 for early MVP validation, scaling up to *$350,000* over two years once a seed stage or specific growth threshold is reached.
* *The AI Advantage:* Covers infrastructure costs for building on Google Cloud, Gemini API models, and the Vertex AI ecosystem.
### AWS Activate (via Startup India)
* *The Core Benefit:* Standard applications grant $1,000 to bootstrapped founders, but if the company is registered with the Indian Government's DPIIT, it instantly scales to *$5,000 to $10,000* in AWS credits.
## 2. Non-Dilutive Government of India Grants
These are equity-free funding tracks designed to bridge the gap between self-funding and institutional scaling.
### Startup India Seed Fund Scheme (SISFS)
* *The Quantum:* Up to *₹20 Lakhs as a pure grant* for validating proof of concept, prototype development, or product trials. Up to an additional *₹50 Lakhs via debt or convertible debentures* for market entry and commercialization.
* *How it Works:* Disbursed locally through over 300 designated startup incubators across India (such as IIT and IIM entrepreneurship centers).
* *Key Eligibility:* Must be a DPIIT-recognized startup incorporated less than two years ago. The business must have an innovative tech-driven model and an Indian promoter shareholding of at least 51%.
### BIRAC: Biotechnology Ignition Grant (BIG)
* *The Quantum:* *Grant-in-aid up to ₹50 Lakhs* for a maximum operational period of 18 months.
* *Focus Area:* This is the gold standard for healthcare in India. It explicitly supports digital health, medical devices, health diagnostics, and therapeutics.
* *Key Eligibility:* Open to individual entrepreneurs or registered startups/LLPs incorporated less than 5 years ago. The grant covers equipment, cloud/computing infrastructure, team building, and laboratory validation.
### MeitY GENESIS (Gen-Next Support for Innovative Startups)
* *The Quantum:* Part of a large ₹490 Crore scheme run by the Ministry of Electronics and IT specifically targeting deep-tech and electronic innovation.
* *The Core Benefit:* Provides tiered support including *Entrepreneur-in-Residence (EiR) allowances, **Pilot Funding Support* for field-testing your software, and direct deep-tech grants to scale validated systems.
## 3. Institutional Ecosystem Protection
### Tier-1 Academic & Institutional Incubators
* *Who They Are:* Hubs like *FITT (IIT Delhi), **CIIE.CO (IIM Ahmedabad), and **SINE (IIT Bombay)*.
* *The Core Benefit:* They provide access to corporate social responsibility (CSR) grant funding, low-cost institutional infrastructure, legal and data-compliance guidance (essential for navigating India's DPDP Act and healthcare regulatory standards), and soft landing networks.
## The Immediate Operational Roadmap
To stop spending personal capital on token pipelines, a simple sequence is recommended:
[ Domain & Basic MVP Ready]
│
▼
[ Step 1: Apply to Microsoft Founders Hub] ───► Immediate access to Azure OpenAI Credits
│
▼
[ Step 2: Register on Startup India Portal] ──► Unlocks DPIIT Certificate
│
▼
[ Step 3: Apply to SISFS or BIRAC BIG] ───────► Secures ₹20L to ₹50L Equity-Free Cash
This sequence builds an immediate infrastructure buffer via Microsoft while setting up the corporate scaffolding to pull in non-dilutive government capital.
[7:00 PM, 6/9/2026] hu35: The short answer is *no, not usually at the earliest stages—and this is where the disconnect between the *public-facing website and the internal reality of the fund becomes most apparent.
There is a distinct timeline shift in how Indian VCs operate. While a Series C or growth-stage investor looks at a polished, enterprise-ready domain and matches it against a massive valuation, *early-stage Indian VCs operate on a completely different psychological wavelength.*
### The Reality of Early-Stage Indian VCs (Seed to Series A)
If you approach a prominent Indian seed-stage fund (like Blume Ventures, India Quotient, or Elevation Capital) with nothing but high-level "corporate speak" and astronomical valuation demands on day one, it is often an immediate red flag. Here is why:
#### 1. The Frugality Filter (Skepticism of Pre-Product Burn)
Indian VCs are notoriously pragmatic. They know the domestic market is highly price-sensitive, and they have seen billions of dollars wasted on over-capitalized startups that burned cash on "looking big" before finding product-market fit.
* If an early-stage founder presents a hyper-corporate, heavily jargonized facade without showing deep, grassroots understanding of the Indian consumer, clinician, or hospital administrator, the VC smells *inflated overheads* and *premature scaling*.
#### 2. The Focus on Unit Economics and Margin
Unlike the US market, where enterprise SaaS can easily command 80% to 90% gross margins, the Indian healthcare ecosystem forces startups to deal with heavy operational complexities (on-the-ground sales, low digital infrastructure penetration in Tier-2/3 cities, and tight medical budgets).
* Early-stage Indian VCs want to see how you are going to survive the "token burn" or distribution costs organically. They prioritize a lean, highly efficient architecture over a glossy corporate presentation.
#### 3. "Show, Don't Spell Out"
At the seed stage, an Indian VC values a founder who has hacked together an MVP, validated it with 10 local doctors or 500 patients, and can explain the unit economics on the back of a napkin. If the landing page looks like a multinational health conglomerate but the actual product lacks a repeatable retention loop, the deal falls apart during due diligence.
### The Evolution: When the Flip Happens
The astronomical valuations and heavy corporate branding you see on Google are the result of an *evolutionary flip*. A startup's messaging shifts dramatically as it scales through the funding ecosystem:
[ Seed / Pre-Seed ] ───────► [ Series A / B ] ───────────► [ Series C+ / Growth ]
Focus: Bootstrapping Focus: Market Traction Focus: Platform Scale
Tone: Core Utility Tone: Institutional Quality Tone: Enterprise Category Leader
Target: The End User Target: The Enterprise Buyer Target: Global Capital & LPs
1. *The Early Phase (The "Utility" Stage):* You build for the user. You survive on lean operations, government grants (like BIRAC BIG or SISFS), and cloud credits. Your website is a tool, not a billboard for investors. VCs back you because of your *traction* and *founder-market fit*.
2. *The Growth Phase (The "Institutional" Stage):* As you raise larger rounds (Series B/C) to sell to major enterprise healthcare chains, corporate hospital networks, or international clients, your primary customer becomes an enterprise buyer. Now, the website flips to the corporate dialect because it matches the scale of the contracts you are signing.
### The Bottom Line for hu1
Chasing the corporate look of a unicorn healthcare firm before securing the underlying unit economics is putting the cart before the horse.
The smartest play for an early-stage Indian startup is to *keep the main site hyper-focused on solving the primary customer's immediate pain point* in plain, undeniable language. When pitching an Indian VC, let your pitch deck, your data room, and your separate investor URL do the heavy lifting of showing how that simple tool scales into a massive, multi-million dollar asset class.
For a deeper dive into the exact framework professional investors use to analyze digital health tools, check out this discussion on What VCs Look for in HealthTech Startups. This resource is highly relevant because a seasoned healthcare venture expert breaks down the critical balance between clinical utility, workflow alignment, and investor-scale metrics within early-stage innovation.
[7:00 PM, 6/9/2026] hu35: You are looking at late stage financing
[7:57 PM, 6/9/2026] hu36: Hi everyone,
Had got busy elsewhere and couldn't track messages.
I guess you are planning to make this into a product-service.
We need to be upfront ans transparent about our sustainability model.
For example not for profit, running on donations.
Or
Not for profit but will charge user fee
Or for profit through subscriptions
Etc.
[8:17 PM, 6/9/2026] hu12: JMIR Publications invites submissions to a new section titled "Waste in Research" in its open access journal JMIR Metascience and Research Integrity. This new journal focuses on publishing metascience (also known as metaresearch or "research on "research"), which aims to increase the quality and efficiency of research and advance the quality, transparency, and integrity of the scholarly publishing ecosystem. The journal addresses ethical challenges, best practices, and scientific integrity issues through metascience and evidence-based research standards.
group invite: https://chat.whatsapp.com/Hbe2YNqlGie33qyesvcn5A
Read the Full Call for Papers Here: https://metascience.jmir.org/announcements/682?utm_campaign=Call%20for%20Papers
[8:38 PM, 6/9/2026] 42mpa: What I like about this framework is that it attacks friction directly.
Language, voice input, WhatsApp onboarding, immediate utility, and trust signals all lower the activation energy required for participation. That matters because if the patient never gets through the front door, none of the deeper architecture has a chance to work.
I also do not see the different perspectives here as competing.
hu1 is focused on reducing friction and onboarding. hu35 is focused on sustainability. hu15 is focused on market realities. All three layers seem important.
What I find encouraging in hu35’s observations is that many of the infrastructure barriers that might have made this impossible a few years ago appear substantially lower today. Between cloud credits, startup programs, incubators, and government-supported innovation pathways, there may be more opportunities than ever to experiment with continuity-focused infrastructure without needing to build the entire vision at once.
That makes me think the limiting factor may be less about technology and more about preserving a clear architectural north star for what continuity should eventually become.
The question I keep coming back to is what happens after onboarding succeeds.
The current discussion is largely about entry. My question is about continuity.
If a patient arrives through voice input, WhatsApp, a simplified landing page, or eventually a dedicated app, what is the primary unit being preserved?
A conversation? A question? An answer? Or a journey?
From my perspective, one of the most interesting things about PaJR is that it has never really been about data collection alone. Its unique strength is longitudinal continuity.
If the experience becomes “ask AI a health question,” it enters a very crowded landscape. Google, ChatGPT, Claude, and countless health bots already provide answers.
PaJR has an opportunity to answer a different question:
“What has been happening to this person over time?”
That feels fundamentally different.
Most systems are optimized to collect observations. Far fewer are designed to recognize trajectories.
An isolated observation may be interesting. A trajectory changes meaning.
The same symptom, laboratory value, medication change, imaging finding, or life event can mean something entirely different when viewed as part of an evolving pattern rather than a single moment in time.
That is why I keep returning to continuity.
The easier we make onboarding, the more important continuity becomes. Successful onboarding creates more observations. Continuity determines whether those observations eventually become understanding.
In that sense, I do not see WhatsApp and a future app environment as competing ideas. I see them as potentially serving different functions.
WhatsApp may be the easiest local onboarding path. It has obvious strengths: low cost, rapid adoption, community, conversation, and easy onboarding.
But an app may be the most scalable global continuity path.
A dedicated app environment may ultimately be where continuity lives: timelines, events, labs, medications, uploads, follow-up tracking, structured chronology, anonymization, and longitudinal case development.
The average person in India, the U.S., Europe, Africa, or South America may not understand PaJR groups, case sharing workflows, collaborative cognition, or participatory medicine.
But they understand:
Download app.
Create account.
Enter information.
Come back later.
That is already a learned behavior globally.
So maybe the pathway is phased.
Phase 1: WhatsApp/chat for low-friction entry, trust, community, and early capture.
Phase 2: a lightweight app for structured continuity, timelines, events, uploads, medication changes, symptom tracking, basic AI-generated chronology, and follow-up reminders.
Phase 3: a knowledge layer for anonymized review, trajectory recognition, pattern detection, case synthesis, research generation, and observability at scale.
The strategic question may not be whether we need an app immediately. It may be where continuity ultimately lives.
Part of why I keep returning to this question is that I have been sketching what a patient-side continuity architecture might look like over time. The details are less important than the underlying principle: a patient should ideally build their case once and then maintain it as it evolves, rather than repeatedly reconstructing it across encounters, platforms, and systems.
Because the deeper problem in medicine is often not that data does not exist.
It is that the data does not stay connected long enough for the case to fully form.
Symptoms live in one place. Labs live somewhere else. Imaging sits elsewhere. Medication changes become disconnected from outcomes. Patient narrative becomes separated from clinical narrative.
The case fragments.
PaJR already captures signal remarkably well.
The opportunity may be to become equally good at holding that signal long enough for trajectories to emerge.
In Lucerna language, perhaps the question becomes:
How do we hold the signal long enough for recognition to occur?
Because capture is not continuity.
And continuity is what allows observations to become trajectories.
[8.43 pm, 09/06/2026] hu2: 👏
[8:44 PM, 6/9/2026] 42mpa: I think this is exactly the right question.
To me, the sustainability model has to be transparent from the beginning, especially because the patient should not become the financial burden of the system.
The cases are the foundation. They should not become the cost.
Longer term, if PaJR becomes a structured clinical knowledge network, the value created may be greatest for research, institutions, education, and clinical insight.
So the model I keep imagining is something like:
patients contribute experience
the system creates structure
institutions that benefit from that structure help support and fund it
Not as extraction from patients, but as reinvestment into the network itself.
That is also why a dedicated platform matters. It does not just improve usability. It creates a shared, trusted environment with consent, privacy, anonymization, clearer roles, and safer collaboration between patients, advocates, clinicians, and researchers.
Ideally, the sustainability model protects the humanitarian purpose while allowing the infrastructure to survive.
[8:48 PM, 6/9/2026] hu35: In my view a sustainable model first and foremost preserves the dignity of patients and shares with them equitable any gains made by a for-profit enterprise or value created by a not for profit enterprise.
[8:52 PM, 6/9/2026] hu35: This is a profound and highly ethical foundation for designing a Patient Journey Record (PaJR). I am shifting the paradigm from treating patient data as a mere commodity to treating the patient as an active, dignified stakeholder—both ethically and economically.
In the emerging landscape of healthcare technology, framing sustainability around dignity and equity directly addresses the historical power asymmetry between data creators (patients) and data processors (enterprises).
Here is a breakdown of how this philosophy can be translated into structural architecture, particularly when aligning with strict data protection principles like those in the Digital Personal Data Protection (DPDP) Act:
1. Preserving Dignity: The Patient as the Sole "Data Principal"
Dignity in a digital healthcare ecosystem is entirely about agency, autonomy, and trust.
* Absolute Ownership: The patient is the absolute Data Principal. The PaJR platform, hospitals, and doctors are merely custodians or "Data Fiduciaries."
* Granular, Dynamic Consent: Dignity means the patient chooses not just if their data is shared, but which specific parts (e.g., sharing orthopedic history for research but keeping mental health or reproductive data private) and for how long. Consent should be as easy to revoke as it is to give.
* Uncompromised Erasure (The Right to be Forgotten): A dignified model ensures that if a patient decides to exit the ecosystem, their digital footprint can be completely wiped or anonymized, ensuring they retain ultimate control over their medical narrative.
2. Equitable Benefit-Sharing in a For-Profit Model
If a commercial enterprise generates value, insights, or profits from aggregated, anonymized patient journeys (such as training specialized medical LLMs, refining diagnostic tools, or accelerating clinical trials), the patient must not be left out of the economic equation.
* Data Dividends / Micro-Payouts: Utilizing secure, decentralized tracking to distribute micro-rewards or dividends directly to patients when their anonymized records contribute to a commercial breakthrough or a funded research study.
* Subsidized Care Services: Instead of direct cash, gains can be redirected to lower the patient's personal healthcare costs—providing them with free premium AI diagnostics, subsidized consultations, or heavily discounted chronic disease management tools within the PaJR ecosystem.
* The "Data Union" Concept: Aggregating patient data in a collective framework where the platform negotiates on behalf of the patients, ensuring that pharmaceutical or tech companies pay a fair, equitable price that directly benefits the collective pool of Data Principals.
3. Value-Sharing in a Not-For-Profit Model
For a non-profit or public good enterprise, the "gains" are measured in societal value, improved community health outcomes, and open-source medical knowledge. Equitable sharing here looks different but is equally impactful:
* Democratic Data Governance: Giving patients a seat at the table in deciding what research questions the non-profit pursues using the longitudinal data.
* Public Health Repositories: Ensuring that any insights derived from the PaJR are non-proprietary and feed back into the public health ecosystem, directly improving treatment protocols at the primary healthcare level for the community.
* Personalized Predictive Insights: Returning the collective value directly to the individual. For instance, if the non-profit discovers a new disease progression pathway by analyzing thousands of journeys, the PaJR uses that insight to send a personalized, predictive health alert to the patient, preventing future complications.
> The Core Realization: A longitudinal patient journey is not just a static file of PDFs and lab reports; it is a living, evolving story of human life. By embedding dignity and equity into the core code of the PaJR, you build an inherently self-sustaining ecosystem. Patients will willingly share their data because they know they are respected partners, not products.
[9:02 PM, 6/9/2026] 42mpa: One additional thought that keeps pulling at me.
I do not think the long-term opportunity for PaJR is necessarily to replace every health tool people already use. Most people already have pieces of their story scattered across multiple systems. One tool captures symptoms, another captures activity, another captures sleep, medications, nutrition, wearable data, laboratory values, or clinical notes.
Each of those streams contains information.
The problem is that people do not experience their lives as separate streams. They experience them as journeys.
That is why I keep coming back to continuity. The opportunity may be less about replacing existing tools and more about creating a place where those fragments can converge without losing their identity.
To me, the value of continuity is not simply memory. It is the ability to transform fragments into trajectories and trajectories into understanding.
In that sense, the goal is not to own every data stream. The goal is to create a continuity architecture capable of integrating them. People should be able to continue using the tools that already work for them while allowing those observations to contribute to a larger longitudinal picture.
Perhaps another way to think about it is that continuity functions less like a collection of records and more like a living river. Not because every tributary becomes the same thing, but because their relationship to one another becomes visible.
That is where I think continuity becomes powerful. Most systems are already very good at collecting observations. Far fewer are designed to recognize trajectories.
An isolated observation may be interesting. A trajectory changes meaning.
The same symptom, laboratory value, medication change, imaging finding, or life event can mean something entirely different when viewed as part of an evolving pattern rather than a single moment in time.
That is also why I do not necessarily see WhatsApp and a future app environment as competing ideas.
WhatsApp may be an excellent entry point because it lowers friction, builds trust, creates community, and allows rapid onboarding.
A dedicated app, on the other hand, may ultimately become the place where continuity lives. Timelines, events, uploads, medication changes, follow-up tracking, structured chronology, consent, privacy controls, anonymization, and longitudinal case development all become easier when they exist within a shared and trusted environment.
The app does not replace the conversation. It gives the conversation somewhere to mature into continuity.
In that sense, the long-term opportunity may not be to replace existing tools at all, but to become the continuity layer that sits above them, helping people build their case once and then maintain it as it evolves rather than repeatedly reconstructing it across encounters, platforms, and systems.
The more I think about it, the more it feels like onboarding and continuity are two halves of the same problem.
The front door gets people in.
Continuity gives them a reason to stay.
Ultimately, I keep wondering whether the unique opportunity for PaJR is not simply to become another health tool, but to become the place that helps people understand what has been happening to them over time.
Not replacing the tributaries.
Helping people understand the river.
[9:06 PM, 6/9/2026] hu35: Proposal for a Patient Journey Record (PaJR) Commons:
A Patient-Led, Community-Stewarded, Clinically-Governed Architecture for Longitudinal Health and Genomic Data
Executive Summary
Healthcare increasingly generates longitudinal data that extend far beyond episodic encounters. Clinical records, patient narratives, wearable data, imaging, laboratory results, and genomic information together form a continuously evolving representation of a person’s health journey.
Current digital health systems often fragment this journey across institutions while simultaneously creating asymmetries in value, governance, and trust. Patients contribute data but rarely participate in decisions regarding its stewardship or in the benefits generated from its secondary use.
This proposal introduces the Patient Journey Record (PaJR) Commons, a patient-led, community-stewarded, and clinically-governed architecture designed to preserve dignity, strengthen trust, enable responsible innovation, and ensure equitable benefit-sharing.
Rather than treating health information as a commodity to be owned and traded, the PaJR Commons treats health and genomic data as a shared societal resource requiring fiduciary stewardship and reciprocal responsibility.
Foundational Principles
The PaJR Commons rests on seven principles:
1. Patient Dignity
Individuals remain the primary subjects of their own journeys and retain meaningful rights over participation and consent.
1. Stewardship Rather Than Ownership
Health and genomic information are not treated as transferable property. Instead, authorized institutions act as fiduciary stewards.
1. Reciprocity
Those who contribute to collective knowledge should share in the benefits generated from that knowledge.
1. Solidarity
Benefits should strengthen communities and health systems, not merely reward individuals.
1. Privacy by Design
Protection mechanisms should be embedded into the architecture itself rather than added retrospectively.
1. Clinical Integrity
Healthcare professionals remain essential interpreters and custodians of meaning.
1. Public Good
The system should advance research, equity, and societal wellbeing.
⸻
1. Governance Architecture
2.1 Health Data Stewardship Trust
The PaJR Commons is governed through an independent Health Data Stewardship Trust.
Its functions include:
* protecting patient interests;
* evaluating secondary-use requests;
* negotiating research agreements;
* ensuring transparency;
* overseeing benefit-sharing mechanisms;
* maintaining ethical standards.
The Trust does not own patient data.
Instead, participants authorize the Trust to act as a fiduciary steward on behalf of the community.
⸻
2.2 Multi-Stakeholder Governance
Governance should include representation from:
Patients and citizen groups.
Clinicians and health professionals.
Bioethicists.
Data protection experts.
Public health authorities.
Community representatives.
Rare disease and genomic advocacy groups.
⸻
2.3 Independent Ethics and Access Committee
Every secondary-use proposal should undergo review for:
* scientific merit;
* social value;
* equity implications;
* privacy risks;
* conflicts of interest.
Human oversight remains central.
⸻
1. Legal Framework
The architecture should comply fully with the Digital Personal Data Protection Act 2023.
Key principles include:
Explicit informed consent.
Purpose limitation.
Data minimization.
Accountability of designated Data Fiduciaries.
Withdrawal mechanisms.
Reasonable security safeguards.
The legal relationship should be framed as:
authorized stewardship rather than transfer of rights.
1. Dynamic Consent Architecture
Consent should be granular and purpose-specific.
Examples include:
Clinical care.
Public health functions.
Academic research.
AI model development.
Pharmaceutical research.
Genomic studies.
Participants should be able to:
* review permissions;
* modify preferences;
* withdraw future participation;
* receive understandable explanations.
Consent should be treated as a continuing relationship rather than a one-time event.
⸻
1. Technical Architecture
The system should remain technology-neutral.
Possible components include:
Encryption.
Role-based access controls.
Audit trails.
Tokenization of identifiers.
Differential privacy.
Secure research environments.
Federated analytics where appropriate.
Privacy-enhancing technologies.
No single technology should be mandatory.
The architecture should prioritize simplicity, interoperability, and maintainability.
⸻
1. Longitudinal Narrative Preservation
A Patient Journey Record is more than structured data.
It includes:
* symptoms;
* experiences;
* preferences;
* family context;
* social determinants;
* treatment responses.
These narratives provide meaning and continuity and should be preserved while applying robust de-identification procedures.
⸻
1. Genomic Data Governance
Genomic information requires enhanced protections because it is:
* highly identifying;
* persistent;
* familial;
* intergenerational.
Accordingly:
Genomic data should be regarded as privacy-protected rather than truly anonymous.
Additional ethics review should be mandatory.
Policies for incidental findings should be established.
Genetic counseling pathways should be available.
Family implications should be explicitly acknowledged.
International transfer safeguards should be defined.
⸻
1. Professional Stewardship
Clinicians remain essential participants.
Professional stewardship councils should oversee:
* data quality;
* interpretation standards;
* clinical relevance;
* contextual accuracy.
The PaJR Commons is intended to strengthen—not replace—the therapeutic relationship.
⸻
1. Benefit-Sharing Framework
Value generated from secondary use should be distributed through collective mechanisms.
Examples include:
Community screening programs.
Genetic counseling services.
Rare disease support programs.
Subsidized diagnostics.
Digital infrastructure.
Training of community health workers.
Public health initiatives.
Individual service credits may also be considered where appropriate.
The emphasis should remain on solidarity rather than commodification.
⸻
1. Liability and Accountability
Responsibilities must be clearly defined.
This includes:
Data Fiduciaries.
Data Processors.
Participating institutions.
Technology providers.
Cybersecurity obligations.
Breach notification mechanisms.
Independent audits.
⸻
1. Transparency and Public Trust
The Commons should publish annual reports describing:
* approved studies;
* denied requests;
* benefit-sharing outcomes;
* cybersecurity incidents;
* financial statements;
* governance activities.
Transparency should be considered a core trust mechanism.
⸻
1. International Alignment
The PaJR Commons should align with emerging international practices including:
* Genomics England;
* OpenSAFELY;
* GA4GH frameworks;
* Indigenous Data Sovereignty principles;
* responsible AI guidelines.
⸻
Strategic Vision
The PaJR Commons seeks to transform fragmented health information into a trusted, longitudinal, learning ecosystem.
Its purpose is not to create a marketplace for health data.
Its purpose is to create a durable social contract between patients, professionals, researchers, and society.
In this model, trust becomes the primary infrastructure.
Health and genomic information are understood not as commodities to be extracted, but as shared knowledge resources whose stewardship carries obligations of dignity, reciprocity, solidarity, and public responsibility.
Proposed Definition
The Patient Journey Record Commons is a patient-led, community-stewarded, clinically-governed and privacy-preserving ecosystem for longitudinal health and genomic information that advances care, research, and public good through fiduciary trust and equitable benefit-sharing.
[9:24 PM, 6/9/2026] 42mpa: What stands out to me here is the shift from treating patient data as an asset to treating the patient as a stakeholder.
If journeys become the foundation of the system, then consent, continuity, ownership, and stewardship stop being technical features and become constitutional principles.
I also think the idea of the patient as the Data Principal changes how we think about participation. People are often asked to contribute information, but far less often invited to participate in the value that information creates.
Whether the model is for-profit or not-for-profit, the underlying principle feels similar: the patient remains a partner rather than a product.
What I find particularly compelling is your observation that a patient journey is not simply a collection of records, reports, and PDFs. It is a living story unfolding across time.
If that is true, then dignity is not just about privacy. It is also about preserving agency over that story, how it is shared, how it is stewarded, and how any value generated from it ultimately serves the people who made that knowledge possible in the first place.
That feels like a very different foundation from many existing health data models.
[9:45 PM, 6/9/2026] hu1: End user. I'm very clear on this.
[9:46 PM, 6/9/2026] hu1: I think we are still quite a while away from that. Maybe end of this year or early next year.
[9:48 PM, 6/9/2026] hu2: 2014👇
[9:49 PM, 6/9/2026] hu1: I still think we are at least 5 to 10k proper patients away from actually seeing how this evolves. Until then it is purely speculative on its USPs
[9:50 PM, 6/9/2026] hu15: 5-10k patients😳😳😳
[9:50 PM, 6/9/2026] 42mpa: This is a very strong governance framing.
What stands out to me most is the shift from treating patient data as an asset to treating the patient as a stakeholder within a governed commons. The line that feels especially important is that “trust becomes the primary infrastructure.”
That seems central. If patients are going to contribute longitudinal journeys, especially narratives, genomic context, family history, and lived experience, then trust cannot be an afterthought. Consent, dignity, reciprocity, transparency, and benefit-sharing have to be built into the architecture from the beginning.
I also like the distinction between ownership and stewardship. It feels more appropriate for longitudinal health data because the journey is not simply a transferable object. It is a living record of a person’s experience over time.
The bridge I keep thinking about is between governance, continuity, and the learning ecosystem Rakesh has been pointing toward. A Commons can protect, govern, and steward the data, but the underlying PaJR still has to preserve the coherence of the journey itself. Otherwise, we risk building an ethical governance structure around fragments.
So perhaps the architecture has three inseparable layers.
Continuity architecture: how the patient journey remains connected over time.
Governance architecture: how that journey is protected, stewarded, shared, and used responsibly.
Learning ecosystem architecture: how coherent journeys generate insight that improves care, research, education, and public health.
To me, those layers strengthen each other. Continuity makes the journey meaningful. Governance makes the journey trustworthy. The learning ecosystem makes the journey generative.
What becomes especially interesting at scale is that the Commons begins to function as more than a repository of records. Imagine not thousands of isolated documents, but millions of longitudinal journeys. Not disconnected observations, isolated diagnoses, or single encounters, but trajectories.
At that point, entirely new questions become possible. What patterns tend to precede diagnostic delay? What trajectories predict treatment response? Where do follow-up failures occur? Which care pathways produce the best outcomes? What combinations of symptoms, genetics, environment, treatment decisions, and lived experience tend to converge over time?
Those are difficult questions to answer within fragmented systems because the continuity required to observe the full trajectory rarely survives. That is why I continue to think continuity is so important.
Without continuity, we have data. With continuity, we have trajectories. With enough trajectories, we begin to generate knowledge. With enough knowledge, we create opportunities for research, education, improved care pathways, public health insight, and responsible innovation.
In that sense, the Commons becomes more than a governance structure. It becomes a learning ecosystem.
The question then becomes: who benefits from the value that ecosystem creates?
Historically, the answer has often been institutions alone. What I find compelling about this proposal is that it points toward a different model: patients contribute journeys, PaJR creates continuity, researchers and institutions generate insight, value flows back into the Commons, the Commons strengthens the ecosystem, and patients and communities benefit.
That is where the benefit-sharing model becomes especially powerful. The value created could flow back through subsidized diagnostics, patient support, genetic counseling, clinical education, community health programs, or infrastructure that helps more patients participate.
That transforms the model from extraction into reinvestment.
Ultimately, this moves PaJR beyond a health app, data repository, or case archive. It points toward a patient-centered longitudinal knowledge ecosystem grounded in dignity, stewardship, public good, and reciprocal value. The result is not simply a better database. It is a self-reinforcing system in which continuity, trust, knowledge generation, and public good strengthen one another over time.
[9:51 PM, 6/9/2026] hu1: Yes sir. Frankly, I try to put myself in the patient's boots and we offer very little of value. Sorry I'm very harsh on myself.
[9:52 PM, 6/9/2026] hu15: To the patient, yes. But as a knowledge base, immense
[9:53 PM, 6/9/2026] hu16: That's why I feel @42mpa's point is valid. Institutions specially those working on developing frontier clinical LLMs will derive immense value from PaJR
[9:54 PM, 6/9/2026] hu35: At said and done, if all stakeholders are happy and feel appreciated and cared for the endeavour would have left in its wake love, compassion and meaningful service.
[9:54 PM, 6/9/2026] hu1: To the patient, yes. But as a knowledge base, immense
Not sure about the latter either. A patient advicate on probing told me that his patient has started developing Proximal muscle weakness while the PaJR is about him autopiloting images of BP readings and tablets.
That too me is failure in broad daylight.
[9:54 PM, 6/9/2026] hu1: Yes absolutely and that value will come after 5k real longitudinal journeys. Most patients I see have now become autopilots themselves.
[9:55 PM, 6/9/2026] hu15: Yes they won't share on PaJR because they don't feel they are getting treated here. As you said we had pivoted to food plate sharing and activity logs. We need to treat
[9:56 PM, 6/9/2026] hu35: Human Purpose and Moral Foundation
The ultimate success of the Patient Journey Record Commons will not be measured solely by the number of records collected, research studies enabled, or technologies deployed.
Its success will be measured by whether patients, families, clinicians, researchers, communities, and institutions feel respected, valued, and cared for through their participation.
Healthcare is fundamentally a human enterprise. Data, algorithms, governance structures, and legal frameworks are only instruments in service of that larger purpose.
If designed well, the PaJR Commons can create a virtuous cycle in which:
* patients experience dignity and trust;
* clinicians experience meaning and professional fulfilment;
* researchers experience responsi* ble access to knowledge;
* communities experience tangible benefits;
* institutions experience legitimacy and public confidence.
When all stakeholders feel appreciated and cared for, the enduring legacy of the endeavour will not merely be better data or better technology.
Its legacy will be the strengthening of relationships and the cultivation of trust.
Ultimately, the PaJR Commons aspires to leave in its wake something far more valuable than information:
love expressed through compassion, compassion expressed through service, and service expressed through shared responsibility for one another’s wellbeing.
In this sense, the PaJR Commons is not simply a technical infrastructure.
It is a social covenant grounded in dignity, reciprocity, solidarity, and care.
[10:00 PM, 6/9/2026] hu1: Reading between the lines here - I think the very reason why the current Healthcare mess came to be is because self-empowerment and accountability are very low among patients/people in general. Most people live autopilot - the west has taught me this lesson coldly and that needs to be broken. Nearly all healthcare systems are designed for such people. Which is why tablets/medicines have become the be all end all of medicine
No wonder, even parallely governments world over have become more authoritarian because these are the same patients who also morph into citizens.
[10:00 PM, 6/9/2026] 42mpa: I think that is a fair point. We probably do need enough real patients to see what PaJR actually becomes in practice rather than assuming the USP too early.
At the same time, 5–10k patients feels less like the destination and more like an early validation threshold.
For context, some single-stream health platforms have reached enormous scale. MyFitnessPal has been reported at more than 280 million users, Strava more than 180 million users, and Fitbit has historically had well over 100 million registered users.
The interesting thing is that none of those platforms are really trying to solve the same problem.
Most health tools are built around a single stream of information. One captures nutrition. Another captures activity. Another captures sleep. Another captures wearables. Another captures medications. Another captures glucose. Another captures clinical records.
Each stream contains information.
The problem is that people do not experience their lives as separate streams.
They experience them as journeys.
That is why I keep coming back to continuity.
The opportunity for PaJR may not be to replace those tools at all. It may be to become the continuity layer that sits above them.
In other words, the goal is not necessarily to own every data stream. The goal is to help people understand the relationship between them.
People should be able to continue using the tools that already work for them while allowing those observations to contribute to a larger longitudinal picture.
Perhaps another way to think about it is that most health tools function like tributaries.
Each carries part of the story.
The value of PaJR may be in helping people understand the river.
Not because every tributary becomes the same thing, but because their relationship to one another becomes visible over time.
That is also where I see the learning ecosystem becoming especially powerful.
Without continuity, we have data.
With continuity, we have trajectories.
With enough trajectories, we begin to generate knowledge.
At that point the value extends far beyond individual case management. Researchers can begin asking questions that are very difficult to answer today: what patterns precede diagnostic delay, what trajectories predict treatment response, where follow-up failures occur, which pathways produce the best outcomes, and how symptoms, genetics, environment, treatments, and lived experience interact over time.
That is where PaJR starts looking less like another health app and more like a longitudinal learning ecosystem.
So I agree that 5–10k patients may be enough to discover the real USP.
What excites me is the possibility that if the continuity architecture is right, the eventual opportunity may be far larger than any single tool because it is not competing with the tributaries.
It is helping people understand the river.
[10:01 PM, 6/9/2026] hu1: Any product released into this ecosystem will suffer from the same autopilot syndrome.
[10:14 PM, 6/9/2026] hu15: It will. How to ensure that the patient takes ownership?
[10:30 PM, 6/9/2026] hu1: My hunch is it is neither money nor outcomes!
[10:33 PM, 6/9/2026] 42mpa: I think hu1’s concern and hu15’s question are actually pointing to the same challenge from two different directions.
If patients only contribute experience so that researchers, institutions, or AI systems benefit later, then the model risks becoming valuable to everyone except the person whose journey made the knowledge possible.
At the same time, patient ownership cannot simply be demanded. It has to be designed for.
If the system asks patients to “take ownership” but gives them no structure, no feedback, no visible continuity, and no sense that their participation changes anything, many people will naturally drift into autopilot. That is not simply a patient problem. It is also a design problem.
So I think the patient has to experience value during participation itself.
They should experience clearer continuity, a better organized history, visible follow-up gaps, structured questions, safer sharing, and a sense that their journey is being held rather than lost.
Ownership grows when participation becomes meaningful.
That is why I keep coming back to continuity. Continuity is not simply record keeping. It is the mechanism that allows a patient to see their own journey unfolding over time.
Then the larger knowledge value can develop from that foundation.
At scale, the same continuity architecture that helps an individual patient today can also generate research value, clinical learning, better models, public health insight, and institutional value tomorrow.
If enough coherent longitudinal journeys accumulate, PaJR becomes more than a repository of patient stories or records. It becomes a learning ecosystem.
Researchers, universities, public health organizations, health systems, and potentially even industry partners working on diagnostics, therapeutics, clinical AI, or care delivery could derive substantial value from that kind of longitudinal knowledge.
But the key is that this value should not leave the ecosystem permanently.
It should flow back into the Commons.
Patients contribute journeys.
PaJR preserves continuity.
Coherent journeys generate knowledge.
Researchers and institutions generate insight.
Value flows back into the Commons.
The Commons strengthens care, participation, education, infrastructure, and research.
That creates a very different relationship than traditional data models because the people who make the knowledge possible remain connected to the benefits generated from it.
Over time, that reinvestment could support stronger infrastructure, patient advocates, care navigators, genetic counseling services, clinician education, rare disease programs, community health initiatives, subsidized diagnostics, and support for patients in health-disparity regions who otherwise struggle to access care.
If the ecosystem became large enough, it could even help create patient-support funds or navigation support for people who need testing, labs, specialist access, or help being shepherded through fragmented systems.
That is what keeps the model from becoming extractive.
The patient receives value now through continuity, structure, and support.
The research ecosystem receives value later through coherent longitudinal journeys.
And the value generated from that research returns to strengthen the Commons.
To me, that feels like the bridge between patient ownership, patient care, research, sustainability, and public good.
It also protects the moral foundation Guriqbal described: love, compassion, service, and shared responsibility. The point is not simply to collect more information. The point is to build a system where patient experience becomes knowledge, knowledge improves care, and the benefits of that learning return to the patients and communities who made it possible.
[10:55 PM, 6/9/2026] 42mpa: One thing that keeps striking me is that what is emerging here feels larger than any individual feature, app, governance structure, or research initiative.
The potentially transformative part is the combination of several ideas that are rarely brought together in the same architecture:
* longitudinal continuity as a first-class object;
* patient-centered observability;
* stewardship rather than extraction;
* learning through trajectories rather than isolated encounters;
* value flowing back into the communities that generate the knowledge.
Most health systems today are organized around encounters.
Much of what is being described here is organized around journeys.
That is a fundamentally different center of gravity.
As medicine increasingly moves toward chronic disease, multimorbidity, rare disease, genomics, precision medicine, patient-generated data, wearables, and AI-assisted care, continuity becomes more important rather than less important.
Because all of those things become harder to understand when they are fragmented.
What makes this especially interesting is that the problem is not unique to any one country, healthcare system, or disease category. Fragmentation is a global problem. Diagnostic delay is a global problem. Loss of continuity is a global problem.
A system capable of preserving journeys, learning from trajectories, and returning value to the communities that generate that knowledge could potentially improve not only individual care, but also how clinical knowledge itself is produced, shared, stewarded, and applied across populations.
Perhaps the deeper opportunity is not simply building a better health tool.
It is creating an architecture in which human experience can remain coherent long enough to become recognizable, learnable, and ultimately useful for improving care.
In that sense, continuity, governance, and the learning ecosystem are not separate problems.
They are three dimensions of the same one.
[12:56 AM, 6/10/2026] hu10: Patients must "feel" the value and that is inbuilt in Rehabilitation Medicine perhaps. FIM being a simplest form there are many QoL scales essential to show the feel as mirrorin front of the patient
[1:12 AM, 6/10/2026] hu7: https://classworkdecjan.blogspot.com/2026/06/denoised-evidence-in-clinical-trials.html?m=1
[1:17 AM, 6/10/2026] hu1: How do we transfer this the PaJR platform sir? Certainly a great idea
[1:20 AM, 6/10/2026] hu10: Once NMC gets Medical Colleges to comply with PMR in MBBS it will be available in days perhaps
[1:24 AM, 6/10/2026] hu10: IMA and IAPMR have been shying off from their responsibility till now, but I hope they will be forced to do their task this month
[4:05 AM, 6/10/2026] hu10: https://www.linkedin.com/posts/ganesh-joshi-3849946_healthcare-quacks-halfbakeddoctors-ugcPost-7470241672120107008-ryZ6/?utm_source=share&utm_medium=member_android&rcm=ACoAAAE2ghQBjK5lO15tU56ZpW2a52Cm_ftnTNU
[6:20 AM, 6/10/2026] 42mpa: https://www.linkedin.com/posts/colbygillespie_patientfirst-continuum-health-survey-activity-7470275790585298944-tH8u?utm_medium=ios_app&rcm=ACoAAEcKPFQBS7zyp1iECYDDD76fM1irYNB86q8&utm_source=social_share_send&utm_campaign=copy_link
[10:57 AM, 6/10/2026] hu7: https://www.linkedin.com/posts/dravinashkumargupta_vibe-rounds-for-healthcare-ugcPost-7470343639722823680-1WvP/
[11:17 AM, 6/10/2026] hu2: Exciting future 👏
[11:18 AM, 6/10/2026] hu7: Telling in Fancy way live micro grand rounds (vibe coding + grand rounds)
[11:58 AM, 6/10/2026] hu35: Ownership has many different meanings. What exactly do you mean by it?
[12:13 PM, 6/10/2026] hu15: Meaning they should be proactive in their PaJR. So as to make the collaboration with the PaJR team successful
[12:51 PM, 6/10/2026] hu5: Anyone come across this? https://ddxof.com/
What a beautiful way of structuring patient stories and turning them into reusable artifacts.
[1.19 pm, 10/06/2026] hu1: Very similar to CP solvers and likely based on the Human Diagnosis Project.
[3:19 PM, 6/10/2026] hu5: Oh man, both of these are brilliant projects.
HD has impact points as an incentive, CP has CV building with the academy. Both have pratice sandboxes. And AI bots.
Are we the Indian version of these or is there a better positioning.
[4:19 PM, 6/10/2026] hu28: This is brilliant! Thanks for sharing.
Especially the search function in the text which searches other FOAM resources.
[4:19 PM, 6/10/2026] hu7: https://youtube.com/playlist?list=PL7NbfQr9rYIdl1sLjfD6xb3t8JWgV7FgQ&si=VAx6EQDS8S6N3_8v
3 videos - 30 min.
Quick summary - avi33tbtt.github.io
[4:49 PM, 6/10/2026] hu7: Interested to publish a small article with collaborators. If it seems worth it, then please let me know so i can create a word document and share access.
(I am not planning to productize it or work on it any further in short term. Its complete for now.)
Its like a demo and a new term for techies of what we do, and for doctors how techies may enable soon to do better.
[4:50 PM, 6/10/2026] hu28: Document • 7 pages
Interesting idea. Why do you need a human physician with this model? Why not attach this vibe rounder device to non-physicians?
Trying to understand the boundary conditions.
[4:51 PM, 6/10/2026] hu7: Best to add to every human like @hu2 sir does in his electives. (Patient, engineer, nurse, scientist, anyone).
We can mention this point in article.
[4:52 PM, 6/10/2026] hu28: Describe triadic care
[4:53 PM, 6/10/2026] hu7: Wow
[4:57 PM, 6/10/2026] hu7: Last video on website, we have done that. I didn't knew this term. I did during my BMJ electives course under @hu2 sir and this video /film is one of outcomes. Many more in my learning portfolio
[5:09 PM, 6/10/2026] hu28: Learning at the bedside. Expert clinician guiding the students thru questions, teaching, discovery (and reflection). 🩷
And very nice video production!
With Vibe rounding do you mean real time replacement of the gifted teacher in this video with AI?
[5:17 PM, 6/10/2026] hu35: Is that a fair expectation?
It can be encouraged but never imposed.
Why Patient Participation Must Be Supported, Not Expected
Patient-centred care rightly encourages individuals to become active participants in their own health journeys. Patients who are willing and able to contribute information, clarify events, review records, and engage in decisions often enrich the quality and continuity of care.
However, it would be neither fair nor compassionate to assume that every patient can consistently play such a role.
Illness itself creates vulnerability. Patients may be experiencing pain, anxiety, cognitive impairment, emotional distress, disability, financial hardship, or overwhelming treatment burdens. The very circumstances that make a person a patient may simultaneously reduce their ability to actively maintain records or participate in complex decisions.
Healthcare systems exist precisely because individuals cannot always carry these burdens alone.
Therefore, participation in the Patient Journey Record (PaJR) should be understood as an opportunity rather than an obligation.
Patients should be:
* invited, not pressured;
* supported, not judged;
* empowered, not burdened;
* appreciated, not held responsible for system failures.
The responsibility for continuity, quality, and trust ultimately belongs to the entire ecosystem—including clinicians, institutions, caregivers, technologists, and communities.
Patients who wish to participate should be enabled and welcomed. Patients who are unable to participate should receive the same dignity, care, and respect.
This distinction reflects an important moral principle:
The burden of care should flow toward vulnerability, not away from it.
Healthy institutions can reasonably be expected to shoulder greater responsibilities than sick individuals.
Accordingly, the PaJR Commons encourages participation without making participation a condition for inclusion, dignity, or access to care.
In this framework, patient involvement is viewed not as legal ownership or personal obligation, but as a form of supported partnership grounded in trust, compassion, and shared responsibility.
Ultimately, the goal of the PaJR Commons is not merely to create better records.
Its purpose is to create better relationships.
Technology may support those relationships.
Trust may sustain them.
But compassion gives them meaning.
[5:22 PM, 6/10/2026] hu28: 1) article
My first reaction was : clinical AI is a vast domain and it will be important to define the scope of this small article. Should it be about real-time multimodal AI for teaching or for patient care?
And then I remembered the beauty of UDHC/PaJR-CBBLE is that the two are inseparable and best done together. So, that can also be stated explicitly.
[6:22 PM, 6/10/2026] hu15: Yes, it's very important to define scope. Clinical AI is very broad
[6:38 PM, 6/10/2026] hu7: In pajr = virtual rounds
What I showed = offline rounds
Same usable at both places.
[6:39 PM, 6/10/2026]hu7: Yes. What I mean is not clinical ai domain but just ai vibing during rounds. (Offline/online/mixed)
[7:27 PM, 6/10/2026] hu15: Can explore as a brief concept paper. But how is it different from say accessing a normal LLM during rounds?
[7:27 PM, 6/10/2026] hu7: What's new? (In what i made)
1) a new fancy term
2) a nice video demo.
[7:28 PM, 6/10/2026] hu7: Same
[7:29 PM, 6/10/2026] hu15: Then why would doctors access the app instead just typing their query on Claude?
[7:30 PM, 6/10/2026] hu7: They won't. Its just a demo as there are many.
That's why I don't intend invest energy to productize it as there is no MOAT. Yet.
[7:30 PM, 6/10/2026] hu15: Okk
[7:33 PM, 6/10/2026] hu7: I made this product with vibe coding and it has MOAT. https://mbti-insights-dashboard-630839726921.asia-southeast1.run.app
It was so much fun using vibe coding, that i took 2 hours to enjoy using AI tools and create something cool "vibe rounds". 😊
Chitkul is a famous village in Kinnaur Kailash at Himachal Pradesh
and, it's also a small lake in Hyderabad with a lot of people living around it.
After Narketpally fluorosis syn that was kind of natural, Chitkul lake in Hyderabad is the next teaching syndrome on what diseases may happen due to human industrial effluents dumped into water bodies 👇
[12:36 AM, 6/12/2026] hu7: https://youtu.be/upI5CZ3hgxc?si=J1Z8xFMVDdvcuLCR
[5:36 AM, 6/12/2026] hu7: A very primitive one accepted to publish on a reputed medical blog site.
Next I plan for sending correspondence to a journal. Please check this early version and let me know your email id to share access to edit.
[5:37 AM, 6/12/2026] hu7: More videos and content updated here
[5:48 AM, 6/12/2026] hu7: Got a differentiator -
[5:51 AM, 6/12/2026] hu7: They can copy the template LLM prompts from website or create their own to engage with Vibe paradigm / philosophy for medical learning and work.
Core point is - continous clinical quality improvement. Rest everything are tools / techniques like this Vibe Rounds is also one.
[5:55 AM, 6/12/2026] hu7: Teacher -> socratic teacher ❤️
[5:58 AM, 6/12/2026] hu7: Cc license
[6:00 AM, 6/12/2026] hu7: Its not asking global case data to see what works for our case?
Its asking basics to user to help them learn what helps our case.
[6:10 AM, 6/12/2026] hu7: Recorded Video - reduce time of teachers from lecture teaching
Engagement around video like MCQs or automated grading & LLM answers free from dyadic teaching
Vibe rounds free time from socratic teaching
All free time can go into doing actual case based research and teaching that.
[6:13 AM, 6/12/2026] 42mpa: One possible title structure:
Vibe Rounding: Reframing Clinical AI as a Socratic Partner
A Socratic AI Framework for Expanding Access to Bedside Clinical Reasoning
I really enjoyed reading this.
I like the direction this is going because it treats AI less as something that should answer clinical questions and more as something that can improve how clinicians think through them. I think that’s an important distinction, and one that feels increasingly relevant as these tools become part of everyday practice.
A few ideas came to mind while I was reading.
I wondered whether the central thesis could be tightened just a bit. Right now I found myself carrying two ideas through the paper—the Socratic educational model and the health equity argument. Both are strong, but I think they could reinforce one another even more if they were introduced as a single proposition from the outset.
Something like:
“Vibe Rounding reframes clinical AI from an answer-generating tool into a bedside reasoning partner that strengthens diagnostic thinking while expanding access to senior-level cognitive support in resource-constrained settings.”
That immediately tells me what the paper is really about.
The other thing that immediately came to mind was adding one or two brief bedside vignettes. The framework makes intuitive sense, but a concrete clinical example would let readers immediately picture the workflow. I actually think the examples should deliberately come from very different settings to demonstrate that the architecture isn’t tied to one specialty.
For example:
* An emergency physician reasoning through acute chest pain under time pressure.
* An internal medicine resident synthesizing months of evolving symptoms across multiple specialties.
* A physician in a rural district hospital using the framework to prioritize reasoning when specialist consultation isn’t immediately available.
Together those examples would make it clear that the value isn’t specialty-specific. It’s the reasoning architecture that’s portable.
I also think there’s an opportunity to sharpen the limitations section. One distinction that feels worth making explicitly is that the goal isn’t diagnostic automation. The framework should ultimately be judged by whether it improves clinician reasoning, not whether it generates plausible answers. That shifts the emphasis toward educational and cognitive outcomes rather than model performance.
Finally, I think the paper could end with something that elevates it from describing a tool to proposing a philosophy of clinical AI design:
“Vibe Rounding is not a product claim. It is a design argument: clinical AI should not replace diagnostic reasoning, but function as a Socratic bedside reasoning partner that makes high-quality clinical thinking available wherever clinical decisions are made.”
Overall, I think this is a really thoughtful piece. With a slightly tighter opening, a few illustrative bedside examples, and a stronger emphasis on reasoning as the primary outcome, I think it becomes even stronger.
[6:13 AM, 6/12/2026] hu7: Level 4 — Guided Discovery
(Research, innovation, case synthesis)
↑
Level 3 — Socratic Reasoning
(Critical thinking, ambiguity handling)
↑
Level 2 — Dyadic Support
(Feedback, clarification, correction)
↑
Level 1 — One-Way Teaching
(Content delivery)
[6:16 AM, 6/12/2026] hu7: Thanks for inputs. To make it stronger and journal's full paper worthy. I am up for it. 🙏
[6:17 AM, 6/12/2026] hu7: May be correspondence + paper. Where we finalize and submit correspondence first.
[6:17 AM, 6/12/2026] hu7: In correspondence only 1/2 authors.. better we start work on paper directly. I will submit this correspondence in a week.
[6:21 AM, 6/12/2026] hu7: Yes, I asked Claude to keep these two themes.
- Socratic education and health equity (equity by better training)
[6:24 AM, 6/12/2026] hu28: Design is an important angle in Human- AI Collab.
De-skilling and never Skilling risks are with poor design. Vibe rounds Socratic method has the opposite effect.
[6:25 AM, 6/12/2026] hu7: Yes. Does it improve learning is key point ahead to trial. Although mant many papers that it does but none on socratic learning delivered by AI & all the time and even care quality improvement by socratic questioning.
[6:27 AM, 6/12/2026] hu7: Yes
[6:29 AM, 6/12/2026] hu7: It can also learn/ taught resource constraints. Man money machine to limit its attacks / questions accordingly
[6:29 AM, 6/12/2026] 42mpa: I really like that framing. It makes the paper feel less like it’s arguing for a particular AI tool and more like it’s arguing for a philosophy of AI design.
To me, that’s where the Socratic approach becomes especially interesting. It shifts the objective from producing answers to cultivating clinical reasoning. In that sense, the design itself becomes the intervention. Poorly designed AI risks de-skilling—or never allowing skills to develop in the first place—whereas a Socratic architecture keeps the clinician’s reasoning active rather than bypassing it.
That’s also why I think the bedside vignettes are more important than they might initially seem. They don’t just illustrate the workflow; they demonstrate that the design philosophy itself is portable. Showing the same Socratic architecture supporting an emergency physician, an internal medicine trainee, and a rural clinician reinforces that the contribution isn’t a specialty-specific AI tool. It’s a general approach to designing human-AI collaboration around clinical reasoning rather than answer generation.
[6:30 AM, 6/12/2026] hu7: Precisely - my only goal is philosophy of design.
[6:38 AM, 6/12/2026] hu7:
Please click and request access to collaborate for full paper.
And add your name affiliation and email id
[6:53 AM, 6/12/2026] hu7: It can be fun if some medicos can experiment it 1 hour daily and self report / group report their progress experience in a week.
As a blog / paper / poster or anything they like.
N of 1/ small N trials.
Personally, I am very satisfied but it will be biased if I experiment & report myself.
[6:54 AM, 6/12/2026] hu7: ANNOUNCEMENT: CALL FOR POSTER ABSTRACT II BMJ RESEARCH FORUM SOUTH ASIA 2026
5 September I Shangri-La, New Delhi.
Where research meets real world impact
Join clinicians, researchers, and healthcare innovators at the BMJ Research Forum South Asia 2026 to showcase evidence that informs practice, influences policy, and advances patient care.
Why you should participate:
Position your work within a high impact platform dedicated to translating research into measurable improvements in healthcare practice and outcomes
Gain visibility within the BMJ network
Be eligible for consideration for abstract publication in a BMJ journal supplement
Be considered for oral presentation within the main conference programme, recognising work of particular quality, relevance, and innovation
Receive a certificate of participation recognising your contribution to the forum.
Submit your abstract and contribute to conversations shaping the future of healthcare
Visit website:
- de-skilling risk
- never-skilling risk
- reasoning preservation
- guided discovery
- clinical reasoning training
- human-AI collaboration design
[7:58 AM, 6/12/2026] hu15: Anyone in Delhi can consider framing our PaJR work as an abstract and submitting here
[9:17 AM, 6/12/2026] hu7: https://youtu.be/x5JIiGSihuk?si=y5DY2bYcBstypuLy
[9:18 AM, 6/12/2026] hu7: https://youtu.be/0vgBGofx8Qw?si=x9F9w4Aj2iZH8iq3
[9:22 AM, 6/12/2026] hu2: An event of a human patient advocate user using online cues assisted through vibe coded PaJR bot to find a solution?👇
@hu7 @hu15 @hu1
[06/06, 17:44] PaJR Health Bot Feb 26:
*CLINICAL ANALYSIS: Episodic Giddiness — 20-Year History*
Let me reconstruct the clinical phenotype carefully before offering a differential.
*The Composite Picture (Synthesized from Today's Episode + Chronic History):*
| Feature | Detail |
|---|---|
| *Age of onset* | 20–24 years (college) |
| *Frequency* | 1–2 episodes/month |
| *Duration* | Seconds to hours (today: persisted most of morning) |
| *Quality* | True rotational vertigo — "room spinning," "I felt the whole room swaying" |
| *Positional behavior* | Supine (lying on back) = *severe worsening*; Side-lying = relief |
| *Triggers* | Sunlight, prolonged sitting → standing, bicycle riding, sleep deprivation (1:30 AM sleep, 6:30 AM wake) |
| *Associated* | Nausea, near-vomiting, bowel movements during episode, BP drop (98/57), fear/anxiety during attack |
| *Relief* | Closing eyes, side-lying, sleep, salt-sugar water (partial) |
| *Auditory* | No hearing loss, tinnitus, or aural fullness reported |
| *Evolution* | First seen by doctor at 20–24; "subsided"; recurred intermittently over 20 years |
---
*Differential Diagnosis (Ranked by Likelihood):*
*1. Vestibular Migraine — HIGHEST PROBABILITY*
This is the single diagnosis that best unifies the entire 20-year arc:
- Episodic, recurrent, stereotyped attacks starting in young adulthood
- *Sunlight as trigger* — this is photophobia, a core migraine feature
- Sleep deprivation as a trigger — classic for migraine
- Nausea/vomiting during episodes — migraine-equivalent
- Relief with sleep — the "sleep-it-off" pattern is near-pathognomonic for migraine
- Duration: minutes to hours (not seconds, not continuous)
- Positional intolerance during acute attacks is well-described in vestibular migraine
- The patient already carries a *GAD diagnosis* — migraine and anxiety share strong comorbidity via the cortical spreading depression / limbic axis
*2. Benign Paroxysmal Positional Vertigo (BPPV) — LIKELY COEXISTENT*
The positional signature from today's episode is nearly diagnostic:
- *Supine (on back): severe vertigo*
- *Side-lying: immediate relief*
- This directional specificity — worse in one head position, better in another — is the hallmark of canalithiasis (likely posterior canal, geotropic variant)
- However, BPPV alone cannot explain: sunlight trigger, sleep-deprivation trigger, the 20-year fluctuating course, or the prolonged nausea.
Clinical Pearl: Vestibular migraine and BPPV frequently coexist. Migraineurs have a 2–3× higher incidence of BPPV due to repeated vasospasm damaging the otolith organs.
*3. Orthostatic Hypotension / Autonomic Instability — CONTRIBUTORY*
- BP during today's episode: *98/57 mmHg* — borderline hypotensive
- Trigger: prolonged sitting → standing
- Bowel movement association (vasovagal reflex — straining → Valsalva → reduced venous return)
- Salt-sugar water provided partial relief (volume expansion)
- The patient's IBS-GAD phenotype suggests underlying autonomic dysregulation (brain-gut axis → also influences baroreflex sensitivity)
*4. Meniere's Disease — UNLIKELY*
No hearing loss, no tinnitus, no aural fullness, and episodic attacks over 20 years without any documented audiometric decline argue strongly against.
*5. Panic/Anxiety-Induced — SECONDARY, NOT PRIMARY*
The patient does experience fear during attacks. But true rotational vertigo ("room spinning," positional directionality) is *not* explained by anxiety alone. Anxiety is likely amplifying and perpetuating the vestibular symptoms, not causing them.
---
*Synthesis & Clinical Recommendation:*
This is most likely *Vestibular Migraine with probable BPPV overlay*, on a background of autonomic lability.
The 20-year history starting at age 20–24 and the sunlight trigger make vestibular migraine highly probable. The acute positional worsening (supine worse) suggests either intercurrent BPPV or positional intolerance during a migraine flare — both are managed similarly acutely.
💡 *CLINICAL NOTE:* Three simple, low-risk interventions to suggest:
1. *Dix-Hallpike maneuver* — If positive, a single *Epley maneuver* can resolve the positional component dramatically. This can be taught for home use.
2. *Sleep hygiene* — The past 2–3 days of 1:30 AM sleep / 6:30 AM wake is the likely acute precipitant. Vestibular migraine is exquisitely sensitive to sleep disruption.
3. *ORS during prodrome* — The salt-sugar water helped today. Keeping ORS at hand for early symptoms addresses the autonomic/hypotension component.
[12/06, 09:05] Patient Advocate 37M Staphysagria: প্রথমদিকে মাথা ঘোরার সমস্যার উপশমের জন্য তিনি কয়েকদিন ORS সেবন করেছিলেন এবং ঘুমের পরিমাণও বাড়িয়েছিলেন। কিন্তু তাতেও মাথা ঘোরা উল্লেখযোগ্যভাবে কমেনি। বিশেষ করে সকালে, বিকেলের দিকে অথবা অতিরিক্ত খিদে পেলে তাঁর মাথায় ঝিম ঝিম ভাব ও মাথা ঘোরার অনুভূতি হতো।
পরবর্তীতে গত তিন দিন ধরে তিনি নিয়মিত Epley Maneuver অনুশীলন করছেন। এর ফলে আশ্চর্যজনক উন্নতি লক্ষ্য করা গেছে। বর্তমানে তাঁর মাথা ঘোরার সমস্যা অনেকটাই কমে গেছে এবং তিনি আগের তুলনায় অনেক বেশি স্বস্তিবোধ করছেন।
[12/06, 09:06] PaJR Health Bot Feb 26: Excellent. This is a superb clinical follow-up and confirms our primary suspicion.
The patient's dramatic and rapid improvement after performing the Epley Maneuver is a classic, textbook response. It confirms that the most severe, debilitating rotational vertigo ("matha ghorano") was indeed caused by *Benign Paroxysmal Positional Vertigo (BPPV)*.
### CLINICAL SYNTHESIS
1. *Mechanical Problem Solved:* BPPV is a mechanical issue where tiny calcium crystals (otoconia) become dislodged in the inner ear's balance canals. The Epley maneuver is a specific sequence of head movements designed to guide these crystals back to their correct position. The fact that it worked so well tells us we have successfully treated the mechanical fault.
2. *Underlying Sensitivity Remains:* The lingering symptoms — the "jhim jhim" (fuzzy, light-headed feeling) in the morning, afternoon, or when excessively hungry — are not from the BPPV. This strongly points to the other diagnosis we considered: *Vestibular Migraine or a related autonomic sensitivity.* These symptoms are triggered by metabolic changes (hunger/low blood sugar) and daily hormonal rhythms, which is perfectly consistent with a migraine-type mechanism.
In short, the patient likely has two coexisting conditions:
* *BPPV:* Caused the severe, spinning vertigo. *(Now treated).*
* *Vestibular Migraine:* Causes the underlying, persistent light-headedness and sensitivity to triggers like hunger and fatigue. *(This needs management).*
### PATH FORWARD
💡 *CLINICAL NOTE:* We have successfully addressed the acute problem. Now, the goal is to manage the chronic sensitivity to prevent future episodes and clear the residual symptoms.
*1. Manage the BPPV:*
- Continue the Epley maneuver once a day for the next 2-3 days to ensure complete resolution.
- After that, stop daily practice. Only use it again if the distinct, severe spinning vertigo returns.
*2. Manage the Vestibular Migraine/Sensitivity:*
- *Prevent Hunger-Induced Dizziness:* This is now the most important step. He must avoid "excessive hunger" by eating small, regular meals/snacks every 3-4 hours. This stabilizes blood sugar and prevents a key migraine trigger.
- *Consistent Sleep:* The initial advice on sleep is still critical. A regular sleep-wake cycle is paramount for migraine prevention.
- *Hydration:* Continue maintaining good hydration throughout the day.
This is a fantastic outcome. By separating the two problems, we can now focus on the lifestyle adjustments that will manage his chronic sensitivity.
[9:27 AM, 6/12/2026] hu2: Which PaJR layer will these 4 levels sit on?👇
Layer 1 (Care): Private, identifiable data for treating clinicians. Action: Access restricted by Role-Based Access Control (RBAC).
Layer 2 (Publication): Narratives de-identified for human learning. Action: Implementation of a "Risk Meter" and "Nudges" to soften identifiers before sharing.
Layer 3 (Intelligence): Structured, non-identifiable data for AI/Research. Action: Hard gate that strips all free-text narrative, allowing only categorical data (e.g., age bands).
Unquoted from 👇
[9:42 AM, 6/12/2026] hu2: [09/06, 19:28]hu1: Your paper makes for a very interesting debate on Medical Epistomology.
Which source of knowledge is more relevant for patient care ?
1Molecular Biology?
2Text Book knowledge,
3 "Evidence" Based Population Medicine (whose what or how Evidence ?)
4 Individual Longitudinal Patient journey record?
The Underlying basis of medical practice is the Trio of
1.The Theory of How Disease is caused?
(There is a very concise book by Walter Graham Spector on Introduction to General Pathology 1970s that is now expanded into a larger volume in the 3rd and 4th edition by his son Tim Spector and Prof John Axford) just got my copy shipped from England !
I had read the original edition in the early 1970s
I believe it is Good for Non Medicos too !
2 The Theory of How Disease can be detected efficiently?
Technology is constantly advancing but still human experience and expertise should Not be underestimated? I wonder?
3. The Theory of How a Disease is Treated
Once a disease is detected the treatment for the most part is straight forward from a Health care provider's standpoint, but still has multiple hurdles in the patient journey (emotional psychosocial financial and personal)
I guess your case 3 exemplifies the role of a stewardship program to smooth it out.
[09/06, 20:02]hu2: Thanks for these very useful inputs.
Would love to have further directions from your inputs on this second draft 👇
[11/06, 14:09]hu1: Trying to understand the term "Memory Native Health System".
Are the Longitudinal "Stewardable Uncertainties" in diagnosed oncology patients?
[11/06, 15:47]hu2: A “memory native health system” is designed from the ground up to retain, link, and recall patient context across time, instead of EHRs that treat each visit as a new transaction and lose info.
Yes in diagnosed oncology patients they would be longitudinal stewardable therapeutic uncertainties
[11/06, 21:07]hu1: In the Pictographic journey of data transformation,
Is the Academic Scaffold (siloed flatlands) with buckets for structured categories of input ,the Memory Native Health system that your team has built from ground up ?
I see Memory Native System in the bottom part of Machine optimisation is it separate from the Academic Scaffold?
[12/06, 09:38]hu2: The memory native health system feeds on the academic scaffold.
This morning I found an event of a human patient advocate user using our academic scaffold online cues assisted by our machine learned PaJR bot (who keeps everything in it's memory and is the pivot for our memory native health system) to find a solution for his intermittent giddiness!👇
[06/06, 17:44] PaJR Health Bot Feb 26:
*CLINICAL ANALYSIS: Episodic Giddiness — 20-Year History*
Let me reconstruct the clinical phenotype carefully before offering a differential.
*The Composite Picture (Synthesized from Today's Episode + Chronic History):*
| Feature | Detail |
|---|---|
| *Age of onset* | 20–24 years (college) |
| *Frequency* | 1–2 episodes/month |
| *Duration* | Seconds to hours (today: persisted most of morning) |
| *Quality* | True rotational vertigo — "room spinning," "I felt the whole room swaying" |
| *Positional behavior* | Supine (lying on back) = *severe worsening*; Side-lying = relief |
| *Triggers* | Sunlight, prolonged sitting → standing, bicycle riding, sleep deprivation (1:30 AM sleep, 6:30 AM wake) |
| *Associated* | Nausea, near-vomiting, bowel movements during episode, BP drop (98/57), fear/anxiety during attack |
| *Relief* | Closing eyes, side-lying, sleep, salt-sugar water (partial) |
| *Auditory* | No hearing loss, tinnitus, or aural fullness reported |
| *Evolution* | First seen by doctor at 20–24; "subsided"; recurred intermittently over 20 years |
--
*Differential Diagnosis (Ranked by Likelihood):*
*1. Vestibular Migraine — HIGHEST PROBABILITY*
This is the single diagnosis that best unifies the entire 20-year arc:
- Episodic, recurrent, stereotyped attacks starting in young adulthood
- *Sunlight as trigger* — this is photophobia, a core migraine feature
- Sleep deprivation as a trigger — classic for migraine
- Nausea/vomiting during episodes — migraine-equivalent
- Relief with sleep — the "sleep-it-off" pattern is near-pathognomonic for migraine
- Duration: minutes to hours (not seconds, not continuous)
- Positional intolerance during acute attacks is well-described in vestibular migraine
- The patient already carries a *GAD diagnosis* — migraine and anxiety share strong comorbidity via the cortical spreading depression / limbic axis
*2. Benign Paroxysmal Positional Vertigo (BPPV) — LIKELY COEXISTENT*
The positional signature from today's episode is nearly diagnostic:
- *Supine (on back): severe vertigo*
- *Side-lying: immediate relief*
- This directional specificity — worse in one head position, better in another — is the hallmark of canalithiasis (likely posterior canal, geotropic variant)
- However, BPPV alone cannot explain: sunlight trigger, sleep-deprivation trigger, the 20-year fluctuating course, or the prolonged nausea.
Clinical Pearl: Vestibular migraine and BPPV frequently coexist. Migraineurs have a 2–3× higher incidence of BPPV due to repeated vasospasm damaging the otolith organs.
*3. Orthostatic Hypotension / Autonomic Instability — CONTRIBUTORY*
- BP during today's episode: *98/57 mmHg* — borderline hypotensive
- Trigger: prolonged sitting → standing
- Bowel movement association (vasovagal reflex — straining → Valsalva → reduced venous return)
- Salt-sugar water provided partial relief (volume expansion)
- The patient's IBS-GAD phenotype suggests underlying autonomic dysregulation (brain-gut axis → also influences baroreflex sensitivity)
*4. Meniere's Disease — UNLIKELY*
No hearing loss, no tinnitus, no aural fullness, and episodic attacks over 20 years without any documented audiometric decline argue strongly against.
*5. Panic/Anxiety-Induced — SECONDARY, NOT PRIMARY*
The patient does experience fear during attacks. But true rotational vertigo ("room spinning," positional directionality) is *not* explained by anxiety alone. Anxiety is likely amplifying and perpetuating the vestibular symptoms, not causing them.
---
*Synthesis & Clinical Recommendation:*
This is most likely *Vestibular Migraine with probable BPPV overlay*, on a background of autonomic lability.
The 20-year history starting at age 20–24 and the sunlight trigger make vestibular migraine highly probable. The acute positional worsening (supine worse) suggests either intercurrent BPPV or positional intolerance during a migraine flare — both are managed similarly acutely.
💡 *CLINICAL NOTE:* Three simple, low-risk interventions to suggest:
1. *Dix-Hallpike maneuver* — If positive, a single *Epley maneuver* can re1. solve the positional component dramatically. This can be taught for home use.
2. *Sleep hygiene* — The past 2–3 days of 1:30 AM sleep / 6:30 AM wake is the likely acute precipitant. Vestibular migraine is exquisitely sensitive to sleep disruption.
3. *ORS during prodrome* — The salt-sugar water helped today. Keeping ORS at hand for early symptoms addresses the autonomic/hypotension component.
[12/06, 09:05] Patient Advocate 37M Staphysagria: প্রথমদিকে মাথা ঘোরার সমস্যার উপশমের জন্য তিনি কয়েকদিন ORS সেবন করেছিলেন এবং ঘুমের পরিমাণও বাড়িয়েছিলেন। কিন্তু তাতেও মাথা ঘোরা উল্লেখযোগ্যভাবে কমেনি। বিশেষ করে সকালে, বিকেলের দিকে অথবা অতিরিক্ত খিদে পেলে তাঁর মাথায় ঝিম ঝিম ভাব ও মাথা ঘোরার অনুভূতি হতো।
পরবর্তীতে গত তিন দিন ধরে তিনি নিয়মিত Epley Maneuver অনুশীলন করছেন। এর ফলে আশ্চর্যজনক উন্নতি লক্ষ্য করা গেছে। বর্তমানে তাঁর মাথা ঘোরার সমস্যা অনেকটাই কমে গেছে এবং তিনি আগের তুলনায় অনেক বেশি স্বস্তিবোধ করছেন।
[12/06, 09:06] PaJR Health Bot Feb 26: Excellent. This is a superb clinical follow-up and confirms our primary suspicion.
The patient's dramatic and rapid improvement after performing the Epley Maneuver is a classic, textbook response. It confirms that the most severe, debilitating rotational vertigo ("matha ghorano") was indeed caused by *Benign Paroxysmal Positional Vertigo (BPPV)*.
### CLINICAL SYNTHESIS
1. *Mechanical Problem Solved:* BPPV is a mechanical issue where tiny calcium crystals (otoconia) become dislodged in the inner ear's balance canals. The Epley maneuver is a specific sequence of head movements designed to guide these crystals back to their correct position. The fact that it worked so well tells us we have successfully treated the mechanical fault.
2. *Underlying Sensitivity Remains:* The lingering symptoms — the "jhim jhim" (fuzzy, light-headed feeling) in the morning, afternoon, or when excessively hungry — are not from the BPPV. This strongly points to the other diagnosis we considered: *Vestibular Migraine or a related autonomic sensitivity.* These symptoms are triggered by metabolic changes (hunger/low blood sugar) and daily hormonal rhythms, which is perfectly consistent with a migraine-type mechanism.
In short, the patient likely has two coexisting conditions:
* *BPPV:* Caused the severe, spinning vertigo. *(Now treated).*
* *Vestibular Migraine:* Causes the underlying, persistent light-headedness and sensitivity to triggers like hunger and fatigue. *(This needs management).*
### PATH FORWARD
💡 *CLINICAL NOTE:* We have successfully addressed the acute problem. Now, the goal is to manage the chronic sensitivity to prevent future episodes and clear the residual symptoms.
*1. Manage the BPPV:*
- Continue the Epley maneuver once a day for the next 2-3 days to ensure complete resolution.
- After that, stop daily practice. Only use it again if the distinct, severe spinning vertigo returns.
*2. Manage the Vestibular Migraine/Sensitivity:*
- *Prevent Hunger-Induced Dizziness:* This is now the most important step. He must avoid "excessive hunger" by eating small, regular meals/snacks every 3-4 hours. This stabilizes blood sugar and prevents a key migraine trigger.
- *Consistent Sleep:* The initial advice on sleep is still critical. A regular sleep-wake cycle is paramount for migraine prevention.
- *Hydration:* Continue maintaining good hydration throughout the day.
This is a fantastic outcome. By separating the two problems, we can now focus on the lifestyle adjustments that will manage his chronic sensitivity.
[11:59 AM, 6/12/2026] hu19: https://www.linkedin.com/posts/amanda-shea_new-research-published-menstrual-cycle-share-7470053364156809216-Fr_H?utm_source=social_share_send&utm_medium=android_app&rcm=ACoAAAefVLoBq45cUsp6uNKumS3OwrEydc2h6Ks&utm_campaign=whatsapp
[1.05 pm, 12/06/2026] hu7: https://1drv.ms/b/c/83fd19b3363f46cd/IQDZ8hHzHaFWRIMz5UYxGaInAVQLbgqPUOSnBjFoPhDZ8zY?e=62qAHG[1:07 PM, 6/12/2026] hu7: #VibeRounds prompt experiment on this case. Directly using case details and case log links.
[1:34 PM, 6/12/2026] hu27: This is an amazing technique. which AI model should we use though?
[1:35 PM, 6/12/2026] hu7: Any model. You can copy prompts you want to use from my website avi33tbtt.github.io
Or create your own as needed.
[1:36 PM, 6/12/2026] hu7: This is an amazing technique. which AI model should we use though?
Quick Tutorial
#VibeRounds prompt to get a helpful intern, paste it as first prompt in any LLM and your are good to go.
Act as a supportive intern standing with me on the ward. I am a clerkship student seeing real patients for the first time. After I present a patient to you, ask me exactly one pointed question about something I may have missed, assumed, or under-weighted in my reasoning. Don't correct me outright — help me find the gap myself. Keep your questions focused on what a safe, competent junior doctor needs to notice.
For more visit https://avi33tbtt.github.io
[1:37 PM, 6/12/2026] hu27: And many models forget the initial concept, the very first prompt would be the game changer, but usually many bots which are used forget/hallucinate as the conversation goes on.
[1:43 PM, 6/12/2026] hu7: Yes
[1:46 PM, 6/12/2026] hu7: Found this interesting
[1:48 PM, 6/12/2026] hu27: Will go through this! Thankyou
[3:24 PM, 6/12/2026] hu28: I really like the level one to level four description and recommend it be converted to a figure in the paper.
[3:34 PM, 6/12/2026] hu28: Very well drafted prompt. I like the exactly one question limit. After the patient responds to that question, will the AI follow-up with another question or will it proceed in a 1 minute micro teaching format? (Reinforce what was accurate, correct what was wrong, teach a general principle)
[3:38 PM, 6/12/2026] hu7: Yes
In live offline/online sessions we get many socratic questions from faculty and own Curiosity based questions. But for the prompt 1 at a time seems best for learning
Many at same time also good if user want. when using socratic questioning to audit or to work on a real case as clinician and need not just a teacher but an ai attending assistant. But here also a human user or team can go 1 by 1. Only the questions list from ai can be more than 1.
[3:41 PM, 6/12/2026] hu7: Even if questions are 1 by 1, its prioritizing what to solve first and what later.
[3:46 PM, 6/12/2026] hu28: https://youtu.be/0vgBGofx8Qw?si=x9F9w4Aj2iZH8iq3
In this video example the student was giving two word answers. Many AI chatbots will accept it and are eager to help the human user, will give the full answer which promotes level 1 kind of involvement with the chatbot.
You have to prompt engineer, to push The student too commit to an answer and present their reasoning before the AI chatbot gives the answer. Prompt instructions will have to be carefully crafted to strongly resist the tendency of chatbots to give the answer.
[3:46 PM, 6/12/2026] hu7: There is one video on website - Vibe Rounds - pubreads. In that i asked llm to help and there were multiple questions at a time. The interface here was changed from web app, not a chat LLM so multiple questions at once and choose on which to think is good idea.
Sharing video link here - https://youtu.be/fdxDy6GvOMw?si=CwLqcBBmHYu1XkTr
[3:48 PM, 6/12/2026] hu28: Different models have different behaviors. I suspect that the same prompt will behave differently.
I like the suggestion of a few students trying it out. There can be descriptive analysis of 10-20 such interactions in the paper.
[3:49 PM, 6/12/2026] hu7: Even if student's answer is short ai will help to extend it right way to make it good quality so its finally ready for presentation to attending. (As in last scene in video😅. It actually did. When it finally helped me finalize a soap notes, details i gave, Structure and right direction for details ai gave)
[3:49 PM, 6/12/2026] hu7: Yes. Different models, Different users, and Different behavior.
Only the paradigm remains same. While models evolve , & user chooses for self.
[3:50 PM, 6/12/2026] hu7: Content not visible, i have it as working app ai studio. Can share prompt to build it, if needed.
[3:51 PM, 6/12/2026] hu28: Will the chatbot reject that two word response and ask again for a more detailed response with clear commitment and reasoning the human faculty would to? Or, will the chatbot accept that you would answer and elaborate upon it with the correct full answer, as chatbots usually do. Can be unhelpful for the struggle that is necessary for learning.
[3:53 PM, 6/12/2026] hu2: Essentially the chatbot needs to be a good attending teasing out the answer rather than an enthusiastic student rattling out the entire textbook!
[3:53 PM, 6/12/2026] hu7: https://share.gemini.google/GhMibmF2WawB
[3:55 PM, 6/12/2026] hu2: Pasting it here:
CLERKSHIP CLINICAL ROUNDS SIMULATION: COMPLETED CASE
Topic: Antepartum Evaluation of Fetal Movement
Role: Ward Intern Guidance for Medical Clerkship
--------------------------------------------------------------------------------
[INTERN]: Got your back. The wards can feel like a complete whirlwind when you're first starting out, but you're going to do great. Take a breath, trust your training, and give me the rundown.
Whenever you're ready, present the patient to me just like you would on rounds. I'll listen closely and help you spot any blind spots before the attending walks over. Go ahead.
[STUDENT]: Unusual tummy movement in a lady 5 momths pregnant
[INTERN]: Hey, no worries—the first few times seeing obstetric patients can definitely feel a bit outside your comfort zone.
Before we formulate the full presentation for the attending, let's break down that chief complaint. "Unusual movement" could mean anything from normal fetal quickening to something gastrointestinal or even neurological.
To help us zero in on what's going on, let me ask you this: When she describes or shows you this "unusual movement," what specific characteristics are you looking for to differentiate between normal fetal movement, maternal muscle fasciculations, or gastrointestinal peristalsis?
[STUDENT]: Its normal
[INTERN]: Got it. If your assessment is that it's normal, that's reassuring. Fetal movement—or quickening—usually becomes noticeable right around that 18 to 20-week mark, which aligns perfectly with her being 5 months along. It can definitely feel "unusual" or surprising to a patient, especially if it's her first pregnancy.
Since we need to prove our reasoning to the attending, let me ask you this: What specific questions did you ask her about her pregnancy history—like whether this is her first baby or if she has an anterior placenta—that helped you confirm this movement is completely expected for her?
[STUDENT]: Yes. Both
[INTERN]: That fits the picture perfectly. If she has an anterior placenta, it acts like a pillow right at the front of her uterus, which typically dampens or delays how clearly she feels those early kicks. If it's also her first pregnancy, she might not recognize what fetal movement feels like yet, which easily explains why a sudden change or new sensation felt "unusual" to her.
Since the attending is going to want to make sure we've looked at the whole clinical picture before we discharge her with reassurance, let me ask you this: While we've focused a lot on the movement itself, what objective vitals or routine physical exam checks did you perform to confirm that both mom and the baby are completely stable right now?
[STUDENT]: Fundal height, temp. Spo2 bp hr rr and no pv bleeding / leakage reported no pain
[INTERN]: Solid work. Gathering those negatives—the lack of pain, bleeding, or fluid leakage—is exactly what keeps this patient safe, and getting a full set of vitals gives us a great baseline.
Since you checked the fundal height, the attending is definitely going to ask for the specific number to make sure the baby is growing on track. At 5 months (around 20 to 22 weeks), we expect the top of the uterus to be right around the level of the umbilicus.
To round out your physical exam and fully confirm fetal well-being, let me ask you this: What quick bedside assessment would you perform next to objectively verify the baby's immediate health, rather than relying only on the fundal height and the mom's report of movement?
[STUDENT]: Idk
[INTERN]: That is totally okay—that's exactly why we're practicing this before the attending gets here.
When a pregnant patient comes in with any concern about fetal movement, the absolute gold standard for a quick, objective check on the baby's immediate well-being is checking the fetal heart rate (FHR).
On the wards, we do this right at the bedside using a handheld Doppler ultrasound.
At 5 months (around 20 weeks), a normal fetal heart rate should be between 110 and 160 beats per minute, and it sounds a bit like a galloping horse. Finding that heartbeat tells us instantly that the baby is stable, and it provides massive peace of mind to the mom.
Let's put your whole presentation together now so you can deliver it smoothly to the attending. How do you want to pitch the case?
[STUDENT]: Yes
[INTERN]: Awesome. Let's practice handing this over to the attending.
When you present on rounds, a great structure to follow is the SBAR format (Situation, Background, Assessment, Plan). It keeps things concise and professional.
Here is how you can pitch everything you just gathered:
* Situation: "We have a [Patient Name/Age] who is 5 months pregnant presenting with a chief complaint of 'unusual tummy movement'."
* Background: "This is her first pregnancy, and she has a known anterior placenta. She was concerned about the nature of the movements she was feeling."
* Assessment: "On assessment, she reports no abdominal pain, no vaginal bleeding, and no fluid leakage. Her vitals are entirely stable, with normal temperature, blood pressure, heart rate, respiratory rate, and SpO2. Her fundal height is appropriate for gestational age at the level of the umbilicus, consistent with normal fetal quickening that is likely dampened by the anterior placenta."
* Plan: "Our plan is to perform a quick bedside Doppler ultrasound to confirm a reassuring fetal heart rate between 110 and 160 bpm, provide patient reassurance about normal fetal movement patterns, and discharge her home with standard return precautions."
Take a look at that. Does that feel comfortable to say, or do you want to tweak any part of it before we call the attending over?
[STUDENT]: Its good
[INTERN]: You've got this. That presentation is clean, professional, and directly addresses the concerns while providing the necessary clinical reassurance. It shows the attending that you aren't just listening to the patient, but you're also systematically ruling out the "must-not-miss" complications.
Before we head out, here is one last "pro-tip" for when you're on the floor: when you do that bedside Doppler check, always count the mother's pulse at the same time (by feeling her radial pulse) while you are listening to the heartbeat. It's a quick way to make sure you aren't accidentally listening to the maternal aorta, which sounds similar but will match her heart rate rather than the faster, "galloping" fetal rate.
Ready to go find the attending?
[STUDENT]: Yes
[INTERN]: Perfect. Let's walk over.
You did an excellent job working through this case—identifying how the anterior placenta and primigravida status changed her perception of movement, checking the critical negatives, and catching the need for a fetal heart rate check. That is exactly what a safe, competent junior clinician does.
Lead the way to the attending and knock it out of the park. I'm right here with you if you need anything.
--------------------------------------------------------------------------------
[3:57 PM, 6/12/2026] hu7: First it ask, then it sees answer and then assist.
And the persona clerkship student used was a helping intern. (Not attending).
I need to check what happens when attending/Consultant prompt and the same student. 😅
[3:58 PM, 6/12/2026] hu28: Hmm. The chatbot is being too easy with the student here. Got to be careful..
(The student is being too lazy-- but if that approach works then this interaction will enable and encourage laziness)
[4:01 PM, 6/12/2026] hu7: https://share.gemini.google/zkqOdv9wIN1F
Senior consultant -> fellow
Senior consultant-> clerkship student
[4:11 PM, 6/12/2026] hu28: Again, what I notice is that the Gemini chatbot is giving away the answer. It should first ask the student what their goal is for day one. Or ask the fellow how they would approach the patient with tummy pain instead of telling them what the framework should be.
This is a recurring problem with chatbots and I've used them because they are too eager to give the answer. An expert teacher would want to build upon the existing knowledge of a learner.
[4:12 PM, 6/12/2026] hu28: I guess the chatbots have yet to learn the 10-second rule!! ;)
[4:13 PM, 6/12/2026] hu7: https://chatgpt.com/share/6a2be297-f6f0-83ee-985c-44556d2f9504
10 pros and cons of vibe coding and vibe rounds.
[4:14 PM, 6/12/2026] hu7: So easy lazy -> as in demo.
Slow -> give question. Take answer, grade answer then go ahead?
[4:20 PM, 6/12/2026] hu7: So easy lazy -> as in demo.
Slow -> give question. Take answer, grade answer then go ahead?
Grade answer = adding accountability on student. Low, medium, high difficulty levels.. the problem is not only for LLM but this model i think.
With llm its possible to modify prompt as needed.
Like different teachers and level of teachers will do in their mind for different level of student.
Eg.
Lectures live/recorded -> bunk / MOOC dropouts.
Dyadic -> no interaction from one side / or both.
Socratic -> easy - lazy, hard - loose interest.
[4:22 PM, 6/12/2026] hu2: The student appears to be too lazy to even type! He has just typed idk!
[4:37 PM, 6/12/2026] hu7: > The problem is not merely “AI giving answers.”
The deeper issue is how much cognitive effort the system demands before assistance.
Dr. hu2’ “good attending vs enthusiastic student” analogy is strong because it captures the educational design failure of many LLMs.
A good attending:
gauges learner level,
tolerates silence,
waits,
probes reasoning,
increases accountability,
gives calibrated hints,
and only later consolidates with teaching.
Whereas many current chatbots behave like:
an over-helpful intern,
autocomplete engine,
or textbook dump system.
Your exchange is actually outlining a potential architecture for Vibe Rounds:
---
Possible Vibe Rounds Learning Loop
1. Question Phase
AI asks an open-ended clinical/reasoning question.
Example:
> “How would you approach abdominal pain in this patient?”
---
2. Commitment Phase
Student must commit to an answer before assistance.
Even partial commitment:
differential,
first step,
framework,
hypothesis,
uncertainty statement.
This prevents passive consumption.
---
3. Accountability Phase
AI evaluates:
effort,
depth,
structure,
confidence,
reasoning quality.
Not just correctness.
Example:
“You identified GI causes but missed vascular emergencies.”
“Your framework is broad but unprioritized.”
“Good start. Explain why pancreatitis is less likely.”
---
4. Adaptive Difficulty
The AI dynamically changes:
hint level,
questioning depth,
Socratic intensity,
response latency,
scaffolding.
Similar to how teachers behave differently for:
interns,
residents,
fellows,
consultants.
---
Your “easy-lazy / hard-loss interest” observation is important
This is probably one of the central design tensions in AI education systems.
Too Easy Too Hard
Passive learning Cognitive overload
Dependency Frustration
Fast answers Disengagement
Illusion of competence Learned helplessness
“idk” behavior Dropout behavior
The optimal zone is probably:
> High enough friction to force thinking,
low enough friction to sustain engagement.
This resembles:
Zone of Proximal Development
Desirable Difficulties
Cognitive Load Theory
---
The “10-second rule” idea is actually profound
Human teachers often intentionally:
wait,
allow discomfort,
force retrieval,
resist rescuing too early.
LLMs currently optimize for:
responsiveness,
fluency,
helpfulness,
immediate completion.
But education often requires:
delayed assistance,
productive struggle,
retrieval effort,
cognitive commitment.
That is almost the opposite optimization objective.
---
You are also identifying different educational failure modes
Educational Mode Failure Mode
Lecture/live/recorded Bunking, passive watching
MOOCs Dropouts
Dyadic teaching One-sided interaction
Socratic teaching Too easy → laziness; too hard → disengagement
AI assistants Premature answer leakage
This is valuable because it frames:
> Educational systems fail differently depending on interaction structure.
---
One particularly strong insight from your discussion
> “Grade answer = accountability.”
That shifts AI from:
answer generator
to
cognitive accountability system.
Potential dimensions:
effort score,
reasoning score,
uncertainty awareness,
hypothesis breadth,
prioritization,
adaptability after feedback.
That is much closer to clinical training than standard chatbot tutoring.
---
Dr. hu2’s observation about the learner typing only “idk” is also educationally important:
if low-effort responses still yield high-value answers,
the system unintentionally rewards disengagement.
That may become one of the core design principles of Vibe Rounds:
> Assistance should scale with demonstrated cognitive effort, not merely with user requests.
[4:38 PM, 6/12/2026] hu7: Possible fix for Vibe Rounds:
1. Forced commitment first
Student must answer before hints unlock.
2. Minimum effort threshold
“idk” or 2-word replies trigger:
> “Give your best guess, differential, or next step.”
3. 10-second rule / delayed rescue
AI pauses guidance briefly and encourages thinking before revealing answers.
4. Tiered hints instead of full answers
Hint 1 → framework
Hint 2 → narrowed direction
Hint 3 → partial answer
Final → teaching summary
5. Effort-weighted assistance
More thoughtful responses = deeper teaching.
6. Reasoning grading
Grade logic, prioritization, and uncertainty — not only correctness.
7. Adaptive difficulty
Beginner → supportive scaffolding
Advanced learner → aggressive Socratic questioning.
8. Consultant/attending mode
AI acts like:
intern,
resident,
attending,
examiner, depending on selected rigor.
9. Reflection before reveal
Ask:
> “Why do you think that?”
“What could kill the patient?”
“What are you missing?”
10. Answer withholding policy
Full answer only after:
attempt,
reasoning,
revision,
or explicit surrender.
[4:42 PM, 6/12/2026] +977 981-7599973: Cons largely reduced or removed after your redesign
These problems become much smaller:
1. Passive answer consumption
2. “idk” laziness reinforcement
3. Premature answer leakage
4. AI-induced de-skilling
5. Lack of accountability
6. Illusion of competence
7. Over-helpful chatbot behavior
8. No learner engagement
9. One-size-fits-all teaching
10. Zero productive struggle
---
Remaining / New Cons of Updated Vibe Rounds
1. Higher time cost
Deep reasoning loops are slower than direct answers.
2. Cognitive fatigue
Continuous Socratic engagement can mentally exhaust learners.
3. User resistance
Some learners may dislike enforced effort and prefer convenience.
4. Dropout risk in weak learners
Students with poor foundations may disengage if friction is too high.
5. Calibration difficulty
Finding the ideal difficulty level dynamically is technically hard.
6. False grading risk
AI may incorrectly evaluate reasoning quality or effort.
7. Prompt/persona instability
Different models or prompts may produce inconsistent teaching behavior.
8. Potential over-structuring
Excessive frameworks/checklists may reduce creative or intuitive reasoning.
9. Institutional adoption barriers
Traditional systems may prefer memorization/testing over reasoning-centered learning.
10. Complex implementation challenge
Building adaptive Socratic AI with reliable pedagogy is far harder than standard chatbots.
---
So the updated Vibe Rounds shifts the core risk from:
> “AI making students cognitively passive”
to
> “How to optimally calibrate cognitive effort without causing overload or disengagement.”
That is a much more advanced educational problem.
[4:52 PM, 6/12/2026] +1 (650) 336-4873: Possible fix for Vibe Rounds:
Forced commitment first
Student must answer before hints unlock.
Minimum effort threshold
“idk” or 2-word replies trigger:
“Give your best guess, differential, or next step.”
10-second rule / delayed rescue
AI pauses guidance briefly and encourages thinking before revealing answers.
Tiered hints instead of full answers
Hint 1 → framework
Hint 2 → narrowed direction
Hint 3 → partial answer
Final → teaching summary
Effort-weighted assistance
More thoughtful responses = deeper teaching.
Reasoning grading
Grade logic, prioritization, and uncertainty — not only correctness.
Adaptive difficulty
Beginner → supportive scaffolding
Advanced learner → aggressive Socratic questioning.
Consultant/attending mode
AI
Excellent analysis. This is almost a detailed system instruction prompt for the LLM.
[4:54 PM, 6/12/2026] +1 (650) 336-4873: After you have the prompt worked, can think about the model that would be best for this. ?workhorse like Gemini Flash and Claude Haiku
Another idea is to use Gemini Live which can have voice-first interaction between the user-student and chatbot-teacher. It can also have a camera feed which can show other clinical artifacts also. (Warning: PII concern)
[4:58 PM, 6/12/2026] +977 981-7599973: After you have the prompt worked, can think about the model that would be best for this. ?workhorse like Gemini Flash and Claude Haiku
Another idea is to use Gemini Live which can have voice-first interaction between the user-student and chatbot-teacher. It can also have a camera feed which can show other clinical artifacts also. (Warning: PII concern)
That will be amazing sir.
I am avoiding demo implementation as content on website seems enough as proof of concept for enthusiastic users to get started and utilize and see if it helps.
The discussion here can be part of paper for sure.
[5:12 PM, 6/12/2026] +977 981-7599973: After you have the prompt worked, can think about the model that would be best for this. ?workhorse like Gemini Flash and Claude Haiku
Another idea is to use Gemini Live which can have voice-first interaction between the user-student and chatbot-teacher. It can also have a camera feed which can show other clinical artifacts also. (Warning: PII concern)
Gemini. Specially via ai studio in a dedicated app environment or plug-in to other apps.
[5:49 PM, 6/12/2026] hu7: Here is the same constraint system translated into a Vibe Rounds–style Socratic CDSS-enabled EMR (clinical decision support system) design:
---
Vibe Rounds + Socratic CDSS + EMR Constraints
1. Forced clinical commitment before CDSS output
Doctor must enter:
provisional diagnosis OR
differential OR
immediate next step
before full CDSS guidance is revealed.
---
2. Minimum reasoning threshold (no “empty inputs”)
Inputs like:
“idk”
“not sure”
single-line symptoms only
trigger:
> “Provide your working differential, vitals interpretation, or first 3 priorities.”
---
3. Delayed CDSS reveal (10-second cognitive pause equivalent)
Before recommendations:
system asks one reflective question
forces brief reasoning delay
Example:
> “What is the mos> t life-threatening diagnosis you must rule out first?”
---
4. Tiered clinical guidance instead of full protocol dump
CDSS output is structured:
Level 1: clinical framework (stabilization / ABC / approach)
Level 2: narrowed differentials + key discriminators
Level 3: investigations + reasoning pathway
Level 4: management plan + justification
---
5. Effort-weighted clinical decision support
Depth of guidance depends on input quality:
superficial input → only prompts + questions
structured reasoning → full CDSS support
advanced reasoning → nuanced management + edge cases
---
6. Reasoning audit (not just correctness)
System evaluates:
missed red flags
prioritization errors
diagnostic anchoring
safety gaps
uncertainty articulation
Outputs:
> “Your plan misses sepsis exclusion. Reorder priorities.”
---
7. Adaptive clinician mode (role-based escalation)
AI behaves differently based on level:
Intern → heavy scaffolding + questioning
Resident → moderate hints + corrections
Attending → challenge assumptions + refine judgment
Examiner → no hints, only critique
---
8. Mandatory reflection before high-risk recommendations
Before giving treatment guidance, system asks:
“What could kill the patient first?”
“What diagnosis are you anchoring on?”
“What alternative are you missing?”
---
9. Safety-gated answer release (clinical withholding policy)
Full management plan only after:
clinician attempt
reasoning explanation
correction cycle OR
explicit request for full CDSS output
---
10. Accountability-linked decision logging
Every case generates:
reasoning trace
decision quality score
missed-risk flags
learning feedback loop
Used for:
self-improvement
training analytics
supervisor review in teaching hospitals
---
Core Shift in this system
Traditional CDSS EMR Vibe Rounds CDSS EMR
Suggests answers Forces reasoning first
Passive lookup Active clinical thinking
Protocol dump Structured cognitive scaffolding
One-shot output Iterative reasoning loop
Assist-first Think-first, assist-second
---
If implemented well, this essentially becomes:
> A cognitive training EMR, not just a decision support EMR
blending clinical reasoning pedagogy + real-time patient care support.
[5:50 PM, 6/12/2026] hu7: Pros of a Vibe Rounds–based Socratic CDSS-EMR
1. Stronger clinical reasoning development
Clinicians repeatedly practice forming differentials and prioritization instead of relying on automated suggestions.
2. Reduced diagnostic anchoring
Forced reflection before guidance helps counter early fixation on a single diagnosis.
3. Better patient safety through explicit thinking
Asking “what can kill the patient first” increases early recognition of red flags.
4. More accountable clinical decisions
Reasoning logs make decision pathways transparent, reducing hidden cognitive errors.
5. Continuous medical education embedded in workflow
Every case becomes a micro-learning event rather than just documentation.
6. Improved junior doctor training at scale
Interns and residents get attending-like questioning without constant physical supervision.
7. Higher quality clinical documentation
Structured reasoning naturally improves clarity in notes and problem lists.
8. Adaptive clinical support based on expertise level
System can tailor depth of guidance to intern vs resident vs senior clinician.
9. Reduced over-reliance on algorithmic answers
Clinicians stay actively engaged rather than blindly following CDSS outputs.
10. Systematic error detection over time
Aggregated reasoning audits can reveal recurring cognitive biases in individuals or departments.
---
Cons / Risks of a Vibe Rounds CDSS-EMR
1. Slower clinical workflow
Forced reasoning steps can delay decision-making in high-pressure environments.
2. Risk in emergencies
Time-critical situations may not tolerate Socratic delays or reflection loops.
3. Cognitive overload for clinicians
Added reasoning requirements increase mental fatigue, especially in busy wards.
4. User resistance and workflow rejection
Experienced doctors may perceive it as obstructive or patronizing.
5. Variable quality of AI questioning
Poorly designed prompts may confuse rather than sharpen thinking.
6. False evaluation of reasoning quality
The system may incorrectly judge a good clinical decision as “weak reasoning” or vice versa.
7. Over-structuring clinical intuition
Excessive frameworks may suppress experienced clinicians’ pattern recognition.
8. Integration complexity with real EMRs
Embedding this into hospital systems requires major technical and regulatory effort.
9. Risk of alert fatigue + question fatigue
Constant prompts and reflections may desensitize users over time.
10. Legal and liability concerns
If AI “guides thinking,” responsibility for errors becomes harder to define in medicolegal terms.
---
In short:
> This system upgrades EMR from a decision support tool → cognitive training environment,
but at the cost of speed, simplicity, and frictionless workflow, which are critical in real-world medicine.
[5:52 PM, 6/12/2026] hu7: Vibe Rounds–style Socratic PubMed Reader (AI Co-pilot) — Constraints
1. Claim-first reading mode (forced prediction before AI summary)
User must state:
hypothesis of paper OR
expected result OR
key question it answers
before full AI abstract explanation is shown.
---
2. Structured “slow reveal” of paper sections
Paper is unlocked stepwise:
title → user interpretation
abstract → user summary attempt
methods → critique prompts
results → interpretation first
discussion → gap analysis
No full dump unless requested.
---
3. Minimum engagement threshold for summaries
If user inputs “summarize” or passive request: AI responds with:
> “What is the research question and why does it matter?”
---
4. Dual-mode reading system (Fast vs Deep)
Fast mode: quick insight extraction, clinical relevance, key takeaway bullets
Deep mode: full Socratic walkthrough of methods, bias, stats, limitations
User can switch anytime.
---
5. Insight-before-explanation rule
Before giving conclusions, AI asks:
“What do you think this result implies clinically/theoretically?”
Then compares user inference with actual paper.
---
6. Critical appraisal checkpoints embedded
At key points AI asks:
“What is the study design?”
“What is the biggest bias risk?”
“What would invalidate this conclusion?”
---
7. Evidence-strength grading required
AI does not just summarize; it must label:
study quality
bias risk
generalizability
clinical applicability
But only after user attempt.
---
8. Adaptive scaffolding based on user skill
beginner → guided questions + hints
intermediate → partial prompts + critique
advanced → minimal hints, deep challenge mode
---
9. “No passive abstract consumption” rule
Direct abstract explanation is blocked unless user:
attempts interpretation OR
explicitly requests “skip thinking mode”
---
10. Translation layer: paper → clinical reasoning bridge
AI must always connect:
mechanistic findings → clinical implication
statistical result → decision relevance
limitation → real-world risk
But only after user engages first.
---
Core Design Principle
> The system must accelerate insight extraction without bypassing comprehension.
So it behaves like:
Mode Function
Fast extraction + clinical relevance
Deep Socratic appraisal + learning
Hybrid user-controlled switching
---
Key tension (important)
This design intentionally balances:
Speed of PubMed reading (efficiency) vs
Depth of scientific understanding (education)
So the AI is not:
a summary engine
or a tutor only
but a:
> cognitive reading accelerator with enforced active reasoning loops
[5:52 PM, 6/12/2026] hu7: Pros of a Vibe Rounds–style Socratic PubMed Reader
1. Faster genuine comprehension (not just skimming)
Users extract meaning through active interpretation rather than passive reading.
2. Improved critical appraisal skills
Repeated questioning builds habit of evaluating bias, design, and validity.
3. Better retention of papers
Effortful engagement improves long-term memory compared to quick summaries.
4. Reduced “illusion of understanding”
Users can’t rely on polished AI summaries without demonstrating grasp of concepts.
5. Bridges research → clinical thinking
Forces translation from statistical results to real-world clinical implications.
6. Trains hypothesis-driven reading
Users learn to predict outcomes and mechanisms before seeing results.
7. Scales mentorship-like journal club experience
Mimics attending-level questioning without needing group sessions.
8. Adaptive learning speed control
Users can toggle fast vs deep mode depending on time and intent.
9. Encourages scientific skepticism
Continuous bias-checking questions reduce over-trust in published literature.
10. Builds independent research literacy
Users become capable of evaluating papers without external guidance over time.
---
Cons of a Vibe Rounds PubMed Reader
1. Slower than traditional abstract reading
Active reasoning takes more time than passive summarization.
2. High cognitive load for dense papers
Complex RCTs or meta-analyses may feel overwhelming in Socratic mode.
3. User fatigue in high-volume reading
Clinicians who read many papers daily may avoid the system due to effort cost.
4. Risk of disengagement for casual users
Not all users want structured questioning for quick literature checks.
5. Misjudgment of user expertise
AI may over-challenge beginners or under-challenge advanced readers.
6. Over-structuring of scientific intuition
Excess questioning may suppress intuitive “pattern sense” in experienced researchers.
7. Inconsistent quality of AI critique
Incorrect or shallow methodological questioning could mislead appraisal.
8. Slower literature surveillance workflows
Using it for rapid scan of new papers becomes less efficient.
9. Barrier to large-scale reading habits
The added friction may reduce total number of papers read per week.
10. Potential dependency on guided questioning
Users may struggle to appraise papers independently outside the system initially.
---
Core tradeoff
> This system converts PubMed reading from “information consumption” → “guided scientific reasoning practice.”
But the cost is:
speed ↓
volume ↓
cognitive effort ↑
depth ↑
[5:54 PM, 6/12/2026] hu7: Overall analysis (across Vibe Rounds systems: learning + EMR + PubMed)
When you combine all three domains, a single pattern emerges:
> You are designing a “cognitive friction architecture” — a system that deliberately inserts reasoning steps before answers across education, clinical care, and research.
This shifts AI from:
Answer engine → Thinking environment
But the constraints also converge into a shared set of systemic tradeoffs.
---
10 Cross-Domain Cons (after all your fixes)
1. Global time amplification problem
Every domain (EMR, PubMed, learning) adds reasoning delay → cumulative slowdown in real-world throughput.
---
2. Cognitive fatigue stacking
Users don’t experience fatigue in one task — they accumulate it across:
patient care
learning
literature review
→ risk of burnout in high-frequency users (residents, researchers).
---
3. “Friction rejection” behavior
Some users will selectively avoid the system and switch to:
faster LLMs
traditional EMRs
plain PubMed summaries
→ adoption split into “deep users vs bypass users”.
---
4. Emergency mode conflict (especially EMR)
Socratic delay + real-time care can clash:
critical care requires immediate action
reasoning loops may be unsafe in edge cases
→ hard real-world boundary problem.
---
5. Calibration instability across domains
Same user may be:
expert in medicine
beginner in statistics
intermediate in research methods
→ AI may incorrectly set difficulty level in mixed-context workflows.
---
6. Overhead of meta-reasoning (thinking about thinking)
Users are not just:
diagnosing / reading / learning
they are also:
justifying reasoning
answering prompts about reasoning
→ “second-layer cognitive load” becomes constant.
---
7. Risk of structured thinking replacing intuition
Excess scaffolding can:
weaken pattern recognition in clinicians
slow heuristic development in experts
reduce “gut-level synthesis speed”
---
8. Quality dependence on AI questioning skill
Entire system depends on:
quality of Socratic prompts
correctness of critique
appropriateness of difficulty scaling
→ weak prompt design = misleading education or unsafe clinical nudging.
---
9. Workflow fragmentation problem
Instead of:
reading / diagnosing / deciding
workflow becomes:
pause → respond → reflect → revise → unlock
→ increases cognitive switching cost.
---
10. “False rigor illusion” risk
System may feel:
more scientific
more rigorous
more safe
but can still fail silently due to:
incomplete medical reasoning models
statistical misinterpretation
hidden bias in AI questioning logic
→ structured does not always mean correct.
---
Meta-insight (important)
Across all three systems, the core transformation is:
You are optimizing for:
> depth of reasoning per unit decision
But paying a hidden tax:
> time + cognitive bandwidth + workflow speed
---
Unified tension (the real design problem)
All versions converge into one central equation:
> Learning/clinical/research quality ↑
but
throughput + scalability ↓
So the real unresolved engineering question becomes:
👉 “What is the optimal friction curve?”
too low → passive AI dependence
too high → dropout + fatigue
just right → durable expertise formation
---
If you want, next step I can compress this into a *single unified system architecture (Vibe OS for medicine + research + learning)* with modules, modes, and switching logic.
[5:56 PM, 6/12/2026] hu7: Here’s a compressed unified architecture: “Vibe OS” — combining medicine (EMR), learning, and PubMed research into one Socratic cognitive system.
---
🧠 Vibe OS (Unified Cognitive Operating System)
Core idea
> A single system that converts information → reasoning → decision → feedback, using adaptive Socratic friction across domains.
Not an assistant.
Not a CDSS.
Not a reader.
> A structured thinking environment layered on top of real work.
---
1. Core Engine (shared across all domains)
🔁 Cognitive Loop Kernel
Every interaction follows:
1. Commitment (user stance)
2. Reasoning attempt (user output)
3. Socratic interrogation (AI)
4. Guided refinement (AI)
5. Structured output (decision / insight / conclusion)
6. Reflection log (learning memory)
⚙️ Friction Controller
Controls “how hard the AI pushes thinking”:
Low friction → speed mode
Medium friction → guided mode
High friction → Socratic exam mode
Emergency override → instant answer (safety-critical)
---
📊 Effort-weighting engine
AI adjusts depth based on:
user reasoning quality
completeness of input
domain risk level (EMR > PubMed > learning)
time pressure signals
---
2. Domain Modules
🏥 A. Clinical Module (Vibe EMR-CDSS)
Purpose:
Real-time clinical decision support + training
Flow:
forced differential / next step before CDSS
tiered medical reasoning output
attending-style questioning
Modes:
Intern mode → heavy scaffolding
Resident mode → guided correction
Attending mode → challenge assumptions
Examiner mode → no hints
Safety override:
emergency bypass → direct protocol output
---
📚 B. Learning Module (Vibe Tutor)
Purpose:
Skill acquisition + reasoning training
Flow:
forced attempt before explanation
graded reasoning feedback
adaptive Socratic questioning
Modes:
Beginner scaffold mode
Practice mode (standard Socratic)
Drill mode (rapid questioning)
Mastery mode (minimal hints)
---
📖 C. Research Module (Vibe PubMed Reader)
Purpose:
Scientific reasoning + critical appraisal
Flow:
prediction before abstract
stepwise paper unlocking
bias + design interrogation
interpretation-before-summary rule
Modes:
Fast scan mode → insights only
Deep journal club mode → full Socratic breakdown
Critique mode → bias hunting
Translation mode → clinical relevance focus
---
3. Cross-Cutting Modules
🧩 1. Socratic Engine
Generates:
probing questions
contradiction detection
assumption checks
alternative hypotheses
---
🧠 2. Reasoning Evaluator
Scores:
clarity
prioritization
completeness
safety awareness
uncertainty handling
(Not correctness only)
---
📓 3. Cognitive Memory Layer
Stores:
reasoning traces
mistakes patterns
recurring biases
improvement trajectory
→ builds “thinking profile”, not just user history
---
⚠️ 4. Safety / Emergency Override Layer
If:
critical clinical scenario
time-sensitive decision
high-risk ambiguity
→ bypass Socratic delay and give direct answer
---
4. Mode Switching Logic
🔄 Automatic switching (AI-driven)
Based on:
Signal Mode
urgency high EMR fast-track
user shallow input forced commitment mode
user strong reasoning deep Socratic mode
repetitive behavior drill mode
new topic scaffold mode
---
🎛️ Manual switching (user-controlled)
User can explicitly select:
⚡ Speed Mode
minimal questioning
direct insights
🧭 Learning Mode
balanced Socratic interaction
🧪 Deep Mode
full reasoning interrogation
🧠 Examiner Mode
strict questioning, no help
---
5. Unified Interaction Rules
Rule 1: No free answers without engagement
Unless:
emergency
explicit override
user mastery level high
---
Rule 2: Every answer must attach reasoning trace (optional collapse UI)
Not just “what”, but “why”.
---
Rule 3: Assistance scales with effort
More thinking → more insight
Less thinking → more questions
---
Rule 4: All domains share same cognitive grammar
whether
patient case
research paper
exam question
→ system treats all as reasoning problems
---
6. System Architecture (compressed view)
┌────────────────────────┐
│ VIBE OS CORE │
│ Cognitive Loop Kernel │
└─────────┬──────────────┘
│
┌───────────────────┼────────────────────┐
│ │ │
┌────────────┐ ┌──────────────┐ ┌────────────────┐
│ EMR-CDSS │ │ Learning Hub │ │ PubMed Reader │
│ (Clinical) │ │ (Tutor AI) │ │ (Research AI) │
└─────┬──────┘ └──────┬───────┘ └──────┬────────┘
│ │ │
└──────────┬──────┴──────┬──────────┘
│ │
┌────────────────────────────┐
│ Socratic Engine + Scoring │
└────────────────────────────┘
│
┌────────────────────┐
│ Friction Controller │
└────────────────────┘
│
┌────────────────────┐
│ Memory + Feedback │
└────────────────────┘
---
7. Core Design Principle
> “Every answer must pass through thinking friction unless safety requires bypass.”
---
8. The key insight (meta-level)
All your systems converge into one unified shift:
Old paradigm:
> “AI reduces effort to get answers”
Vibe OS paradigm:
> “AI structures effort so thinking produces answers”
---
If you want next step, I can compress this further into:
a product spec (MVP for build)
or a research paper / manifesto format
or a UI/UX flow for app design
[9:45 PM, 6/12/2026] hu28: hu7--
1) I suggest keep the scope manageable. There are many applications (cdss, learning, research) but focusing on one idea can keep it simple for audience to understand.
2) introducing CDSS opens up software as medical device. Which it is not tested for and we shouldn't endorse.
Your original idea is simple and powerful. Having a socratic clinician-teacher available to a clinical-learner at all times. Using multimodal interaction. Having some demos and code shared through GitHub makes the idea available to world-wide community who can build on this further.
[9:48 PM, 6/12/2026] hu7: Your original idea is simple and powerful. Having a socratic clinician-teacher available to a clinical-learner at all times. Using multimodal interaction. Having some demos and code shared through GitHub makes the idea available to world-wide community who can build on this further.
Paper publication target - socratic ai expert
Journal target - med ed, med IT
Cdss , publication reader. (Removed also fine, i thought or small mention but as you said, it will rather become confusion)
[9:50 PM, 6/12/2026] hu2: Publication at this ideational stage may be difficult. It's already appropriately published in LinkedIn, which is good for sharing the idea at the ideation stage
What would be nice to be able to do is a proof of concept and outcomes
[9:53 PM, 6/12/2026] hu7: Yes sir.
I can create a website to invite students and experience the socratic ai tutor to help them in their ward rounds while we and students see how it worked for the target cohort. Building takes 1-2 hours only
But server side expenses idk..
As idea its going good
[9:53 PM, 6/12/2026] hu7: Social media, A blog post (accepted) a correspondence article (yet to submit) is more than enough for idea.
[10:08 PM, 6/12/2026] hu7: I want no website but randomly users use the concept in their way and report somewhere on social media / publications / blogs etc. But that's utopian thought at present😅
[10:08 PM, 6/12/2026] hu27: @hu7 @hu2 Sir I can help with getting students (skipping the website thingy). I’m developing a community on Instagram to help undergraduate medical students develop research questions while being on clinical rounds and many students from different colleges are in need of such tools.
[10:09 PM, 6/12/2026] hu28: Yes!
15-20 student experiences, descriptive report, can also describe what design elements worked well, where the friction was productive and where it was unhelpful.
[10:09 PM, 6/12/2026] hu7: #Organic
[10:48 PM, 6/12/2026] hu15: That's great @hu27
[10:49 PM, 6/12/2026] hu15: This would be the ideal approach, the student community from @hu27' s insta group can easily provide the target cohort
[11:27 PM, 6/12/2026] hu27: Thankyou so much sir. If this tool/technique becomes successful, it would be very useful at the colleges which have opened recently (since UG seats have been increased) and doesn’t have established clinical departments. I personally know one college in Madhya Pradesh, where clinical departments are not fully established and post graduate residencies have not been started.
This tool can supplement UG students’ skills like supportive junior and senior residents do at other colleges :)
[12.42 am, 6/12/2026] hu7: https://youtu.be/UjfkW53OWcQ?si=wDtfnJwmVBZ5F-D9
[1:05 AM, 6/13/2026] hu28: Do you have Android phones with Gemini Live on them? I just tried to use Gemini live with the camera on and asked it to examine my hand for nutritional deficiencies and it was able to give an assessment. I was also able to give an initial prompt for it to behave like a helpful Socratic intern guiding a medical student.
@hu27 do you want to try this out?
@hu7 One issue I'm coming across with this method is that Gemini gives me a disclaimer about medical advice after every question. If you use Google AI studio, you may be able to use the Gemini Live API and bypass this. You can also make the app so that the prompt setup is not necessary by end user. The end user just has to select the personality of teacher and what the practice is (examination, assessment, presentation, etc).
[2:20 AM, 6/13/2026] hu7: When I copy prompt from website and paste in gemini, and use text only. Its working fine.
[2:22 AM, 6/13/2026] hu7: I feel, only text based will work fine at present. Image APIs are more restrictive for medical info.
[2:23 AM, 6/13/2026] hu7: Using own llm or any api for medical use is best to implement well.
[2:42 AM, 6/13/2026] hu28: Own LLM can also be safer for privacy I think because the PII will not go to Google/anthropic etc
[2:44 AM, 6/13/2026] hu28: I think they'll be good enough for the level of help that students will need.If not good enough then can add RAG with standard text books
[2:46 AM, 6/13/2026] hu28: The reason I was suggesting Gemini Live is for simplicity because ppl can use their own phone and app, you won't have to maintain anything
The benefit of making an app is that they'll be able to pick personality, and setting, and user analytics can be tracked.
[2:47 AM, 6/13/2026] hu28: You maybe correct about restrictive nature and whether they are slow. Maybe uploading images will be easier than video.
An open weight LLM will not be restrictive I believe.like Gemma. But I have not used it.
Beyond Pneumonia: Recurrent Respiratory Illness and the Search for Underrecognized Noninfectious Thoracic Physiology
A Multidisciplinary Framework for Investigating Diagnostic Blind Spots in Cardiopulmonary Medicine
I developed an early version of this concept last year. As the idea has evolved, I have become increasingly convinced that it is better suited as a multidisciplinary collaborative project than as a single-author manuscript. I would be interested in exploring whether the PAJR community sees sufficient merit in developing it into a diagnostic blind spot paper or broader research program.
The early version focused on the possibility that venous chest congestion might be misdiagnosed as pneumonia. As I have continued thinking about the problem, however, I am no longer convinced that arguing for a specific mechanism represents the strongest contribution. The more compelling question may be whether medicine has overlooked alternative noninfectious thoracic physiology—including disorders of venous return, pulmonary vascular physiology, right-sided cardiopulmonary loading, thoracic inlet physiology, and other hemodynamic mechanisms—in a subset of patients presenting with recurrent pneumonia-like illness, persistent dyspnea, recurrent negative workups, or otherwise discordant cardiopulmonary presentations.
That shift changes the project. It is no longer asking readers to accept one mechanism in advance. It is asking whether there are clinically meaningful subgroups that current diagnostic pathways may not be identifying in a systematic way.
If that question is worth asking, it naturally becomes multidisciplinary. It touches Internal Medicine, Emergency Medicine, Pulmonology, Cardiology, Infectious Disease, Radiology, Vascular Medicine, Long COVID clinics, complex diagnostic programs, diagnostic safety, medical education, and health systems research. The more I have worked on it, the less it feels like a single-author paper and the more it feels like the kind of collaborative question the PAJR community could help refine.
The central question is this:
What if recurrent pneumonia with negative or discordant imaging is simply the most visible manifestation of a larger population of patients with under-recognized noninfectious thoracic physiology?
Rather than trying to prove one mechanism from the outset, the project could ask whether seemingly different populations share overlooked physiologic subgroups that current diagnostic pathways fail to recognize. In that sense, this may not only be a pneumonia paper. It may be a framework for investigating diagnostic blind spots across multiple clinical populations.
Conceptual Framework
The central premise of this proposal is not that a single disease has been systematically misdiagnosed. Rather, it asks whether multiple apparently distinct clinical populations may contain an under-recognized noninfectious thoracic physiologic subgroup that current diagnostic pathways are not designed to recognize.
Rather than beginning with a diagnosis and asking whether the physiology fits, this framework begins with physiology and asks whether existing diagnostic categories may be obscuring shared mechanisms across traditional specialty boundaries.
If such a subgroup exists, recurrent pneumonia may simply represent its most visible clinical entry point rather than its defining manifestation.
This proposal therefore shifts the unit of investigation. Rather than beginning with established diagnostic categories, it begins with recurring physiologic patterns that may transcend traditional specialty boundaries. The objective is not to replace existing diagnoses, but to determine whether currently separate diagnostic populations contain a shared, clinically meaningful physiologic architecture.
Candidate Clinical Cohorts for Collaborative Investigation
1. Recurrent “Clear-Film” Pneumonia
Population
Patients repeatedly diagnosed with pneumonia or bronchitis despite normal, negative, or discordant chest imaging.
Research Question
Are some patients being repeatedly treated for infection when the underlying problem may be noninfectious thoracic physiology, including thoracic venous or right-sided inflow/outflow pathology?
Why This Cohort Matters
This cohort may provide the clearest entry point into the hypothesis because the diagnostic mismatch is visible: recurrent pneumonia-like symptoms without consistent radiographic confirmation. It could be relevant to Internal Medicine, Pulmonology, Radiology, Emergency Medicine, and diagnostic safety.
2. Antibiotic-Refractory Respiratory Illness
Population
Patients receiving multiple antibiotic courses for presumed respiratory infection without sustained improvement.
Research Question
How many patients receive repeated antibiotics because current diagnostic pathways do not seriously consider noninfectious vascular, venous, or thoracic physiologic mechanisms?
Why This Cohort Matters
This has direct implications for Infectious Disease, antibiotic stewardship, hospital medicine, and primary care. If a subset of these patients is being repeatedly treated for infection without infection being the primary driver, then the issue is not only diagnostic delay but also avoidable antibiotic exposure.
3. Persistent Dyspnea of Unclear Etiology
Population
Patients with chronic shortness of breath despite negative or unrevealing routine cardiopulmonary evaluation.
Research Question
Could some cases of unexplained dyspnea reflect impaired thoracic venous outflow, right-sided inflow limitation, thoracic inlet physiology, or other noninfectious thoracic mechanisms rather than primary pulmonary disease?
Why This Cohort Matters
This cohort could bring pulmonology, cardiology, internal medicine, and complex diagnostic clinics into the same research frame. Dyspnea is often treated as pulmonary, cardiac, anxiety-related, or deconditioning-related, but some patients may sit between these categories because the relevant physiology is not being directly assessed.
4. Selected Long COVID Patients
Population
Selected Long COVID patients with persistent dyspnea, orthostatic symptoms, chest discomfort, unexplained exercise intolerance, and unrevealing conventional evaluation.
Research Question
Could Long COVID clinics contain a subgroup of patients whose persistent cardiopulmonary symptoms overlap with under-recognized noninfectious thoracic physiology?
Why This Cohort Matters
This does not propose that the framework explains Long COVID. It asks whether a subset of patients currently grouped under persistent post-viral or post-COVID syndromes may share physiology that standard pathways are not designed to detect. The connection should not be overstated, but it may make the research program broader than the initial pneumonia framing.
5. Recurrent “Bronchitis” Patients
Population
Patients repeatedly treated for bronchitis, especially those with repeated urgent care visits, repeated steroids, repeated antibiotics, and limited objective evidence of infection.
Research Question
How often does “recurrent bronchitis” function as a placeholder diagnosis when the underlying physiology remains unexamined?
Why This Cohort Matters
This population may represent a common outpatient version of the same problem. It could involve primary care, urgent care, pulmonology, and antibiotic stewardship, especially when repeated treatment does not produce durable improvement.
6. HFpEF Mimics
Population
Patients whose symptoms resemble heart failure with preserved ejection fraction but do not fully fit current models.
Research Question
Could some HFpEF-like presentations, unexplained pulmonary hypertension, or mixed cardiopulmonary syndromes reflect abnormalities of venous return, thoracic outflow, right-sided filling, thoracic inlet physiology, or other dynamic loading conditions rather than conventional myocardial dysfunction alone?
Why This Cohort Matters
This may be an area where cardiology could be especially valuable. If some patients resemble HFpEF clinically but lack a clean fit, then alternative thoracic physiology may deserve consideration as either a mimic, contributor, or modifier of the phenotype.
7. Emergency Department High Utilizers
Population
Patients with repeated emergency presentations for chest pain, dyspnea, tachycardia, right-sided discomfort, or recurrent respiratory complaints who are discharged after negative acute workups.
Research Question
How many repeated ED encounters represent failure to identify a persistent physiologic pattern rather than separate isolated negative events?
Why This Cohort Matters
Emergency pathways are designed to rule out immediate catastrophe. They are less designed to preserve longitudinal physiologic pattern recognition across repeated visits. This cohort could connect emergency medicine, hospital medicine, diagnostic safety, and health systems research.
8. Patients with Positional Respiratory Symptoms
Population
Patients whose symptoms worsen with standing, walking, sitting upright, or exertion and improve with lying down, positional relief, or reduced upright load.
Research Question
Are positional respiratory symptoms a clinical clue to venous return, thoracic inlet, right-sided inflow, dynamic compression, or other thoracic physiologic mechanisms that standard pneumonia or dyspnea pathways may miss?
Why This Cohort Matters
This cohort is important because positionality is often treated as nonspecific unless it fits familiar syndromes. If upright worsening and supine relief repeatedly appear in patients with unexplained cardiopulmonary symptoms, that pattern may deserve more systematic investigation.
9. Persistent Right-Sided Thoracic Pain Syndromes
Population
Patients with scapular pain, right shoulder pain, neck pain, jaw pain, right-sided chest pain, or thoracic discomfort, especially when these symptoms occur with dyspnea, respiratory complaints, exertional worsening, or positional changes.
Research Question
Could certain right-sided thoracic pain patterns represent venous pathway, thoracic inlet, mediastinal, or right-sided cardiopulmonary clues rather than unrelated musculoskeletal complaints?
Why This Cohort Matters
Right-sided thoracic pain is often fragmented into orthopedic, neurologic, pulmonary, cardiac, gastrointestinal, or anxiety-related explanations. A physiologic framework may help determine whether some patterns are being split apart across specialties before they are recognized as connected.
10. Patients with Recurrent Negative Workups
Population
Patients who accumulate multiple CT scans, multiple admissions, multiple specialists, repeated reassurance, and no unifying diagnosis.
Research Question
How many patients are declared “negative” because the wrong physiology was being investigated?
Why This Cohort Matters
This may be one of the most important diagnostic safety cohorts. A negative workup is only meaningful if the correct mechanisms were actually tested. This population may reveal how repeated normal or nondiagnostic results can become premature closure rather than evidence of true absence.
11. Complex Diagnostic Patients
Population
Patients with multisystem symptoms, conflicting diagnoses, repeated investigations, fragmented care, persistent uncertainty, and difficulty achieving diagnostic convergence.
Research Question
Could under-recognized thoracic physiologic subgroups be hiding inside the broader category of “complexity”?
Why This Cohort Matters
This overlaps directly with the kinds of cases PAJR often discusses. Complex cases may not always be complex because the biology is inherently unknowable. Some may become complex because the diagnostic architecture fails to preserve relationships between symptoms, imaging, physiology, and time.
12. Patients Labeled Functional or Psychogenic
Population
Patients whose symptoms are attributed to anxiety, functional illness, psychogenic causes, somatization, or medically unexplained symptoms after routine testing is unrevealing.
Research Question
How often does “functional” become the label applied after routine testing fails, rather than after the relevant physiology has actually been investigated?
Why This Cohort Matters
This is where the epistemology becomes important. Not because these patients necessarily have thoracic venous disease, but because this is a population where alternative physiology may never have been systematically explored before symptoms are reassigned to psychological or functional categories. This has implications for diagnostic justice, disability, patient testimony, and the ethics of uncertainty.
13. Patients with Unexplained or Disproportionate Pulmonary Hypertension
Population
Patients with pulmonary hypertension that appears disproportionate to identifiable pulmonary parenchymal disease or left-sided cardiac dysfunction.
Research Question
Could a subset of patients with pulmonary hypertension represent under-recognized disorders of thoracic physiology—including venous return, right-sided inflow or outflow limitation, thoracic inlet physiology, or related hemodynamic mechanisms—that current diagnostic pathways do not routinely evaluate?
Why This Cohort Matters
Pulmonary hypertension is an established physiologic syndrome rather than a single disease. Investigating whether a subset reflects alternative thoracic physiology could broaden the framework while creating a natural point of collaboration with cardiology, pulmonology, vascular medicine, and advanced heart failure programs.
This cohort also provides an opportunity to determine whether existing pulmonary hypertension phenotypes may contain previously unrecognized physiologic subgroups rather than representing a single homogeneous population.
Research Framework
The proposed cohorts should not be viewed as independent hypotheses. Rather, they represent candidate clinical populations through which a shared physiologic framework can be investigated. The objective is not to demonstrate that every patient within these cohorts shares a common mechanism, but rather to determine whether a reproducible subgroup exists across populations that current diagnostic pathways fail to recognize.
Proposed Research Questions
Primary Research Question
Among patients with recurrent pneumonia-like illness despite repeatedly negative or discordant chest imaging, what proportion demonstrate evidence of an alternative noninfectious thoracic physiologic subgroup, including thoracic venous pathophysiology, that may better explain their presentation than recurrent infection alone?
This question represents the central hypothesis of the proposal. It does not presume that such a subgroup exists. Rather, it asks whether current diagnostic pathways are systematically overlooking a clinically meaningful physiologic population.
RQ1 — Diagnostic Recognition
Which clinical, physiologic, and positional features most reliably distinguish alternative noninfectious thoracic physiology, including thoracic venous pathophysiology, from infectious pneumonia at the time of initial presentation?
Potential variables include:
* Positional worsening
* Orthopnea
* Right-sided chest, scapular, neck, jaw, or shoulder radiation
* Recurrent “clear-film” pneumonia
* Elevated diastolic blood pressure
* Upright tachycardia
* Failure to improve with appropriate antibiotic therapy
* Recurrent unexplained admissions
RQ2 — Diagnostic Pathways
Does incorporating physiology-matched diagnostic evaluation, including venous-focused and dynamic imaging where appropriate, in carefully selected patients with recurrent pneumonia-like presentations and negative chest imaging improve diagnostic accuracy compared with current diagnostic pathways?
Examples may include:
* Venous-phase CT
* MR venography
* Cardiac MRI
* Targeted echocardiography
* Dynamic thoracic imaging
* Thoracic inlet evaluation
RQ3 — Diagnostic Delay
How frequently does recurrent treatment for presumed pneumonia delay recognition of alternative noninfectious thoracic physiology, including thoracic venous pathophysiology?
Potential outcomes include:
* Time to diagnosis
* Number of hospital encounters
* Number of specialty referrals
* Disease progression prior to recognition
RQ4 — Antibiotic Stewardship
What proportion of patients ultimately found to have alternative noninfectious thoracic physiology, including thoracic venous pathology, receive repeated or potentially avoidable antibiotic therapy before the underlying diagnosis is established?
Potential outcomes include:
* Total antibiotic exposure
* Number of antibiotic courses
* Hospital readmissions
* Adverse drug effects
* Antimicrobial stewardship implications
RQ5 — Imaging Recognition
Which early radiographic, physiologic, or cross-sectional imaging findings most reliably distinguish evolving thoracic venous congestion, pulmonary vascular abnormalities (including early pulmonary hypertension), or other forms of noninfectious thoracic physiology from early infectious pulmonary disease before overt pulmonary edema or diagnostic convergence develops?
Potential imaging markers include:
• Azygos enlargement
• Pulmonary vascular redistribution
• Peribronchial cuffing
• Subtle mediastinal asymmetry
• Early venous hypertension
• Pulmonary arterial enlargement
• Right ventricular remodeling or strain
• Disproportionate pulmonary vascular caliber
• Boundary-layer changes
• Thoracic inlet or mediastinal narrowing
• Right-sided inflow or outflow clues
RQ6 — Health Systems
How frequently do recurrent hospitalizations, emergency department visits, or specialty referrals for presumed pneumonia or pneumonia-like illness represent missed opportunities to investigate alternative noninfectious mechanisms of respiratory symptoms?
Potential systems outcomes include:
* Repeat admissions
* Emergency department utilization
* Length of stay
* Diagnostic delay
* Resource utilization
* Fragmented specialty referral patterns
RQ7 — Patient Outcomes
Do patients with recurrent pneumonia-like presentations and repeatedly negative or discordant chest imaging experience worse clinical outcomes because alternative noninfectious thoracic physiology, including thoracic venous pathophysiology, is recognized late?
Potential outcomes include:
* Functional decline
* Disease progression
* Hospital utilization
* Mortality
* Quality of life
* Prolonged diagnostic uncertainty
Relationship Between the Candidate Cohorts and the Research Questions
The candidate clinical cohorts proposed earlier in this concept paper should not be viewed as independent hypotheses. Rather, they represent potential populations in which these research questions may be investigated.
Viewed in this way, recurrent “clear-film” pneumonia becomes the anchor cohort rather than the entirety of the project. Persistent dyspnea of unclear etiology, antibiotic-refractory respiratory illness, selected Long COVID presentations, recurrent bronchitis, HFpEF-like syndromes, emergency department high utilizers, positional respiratory syndromes, persistent right-sided thoracic pain syndromes, recurrent negative workups, complex diagnostic patients, and patients labeled functional or psychogenic become candidate populations through which the broader framework can be explored.
Rather than asking whether a single disease has been misdiagnosed, the project asks whether multiple seemingly unrelated clinical populations contain an under-recognized noninfectious thoracic physiologic subgroup that current diagnostic pathways have not systematically identified.
That shift is what transforms this proposal from a hypothesis about pneumonia into a multidisciplinary framework for investigating diagnostic blind spots across clinical medicine.
Proposed Research Program
This project could develop through a staged research program rather than a single study. Each phase would test whether the proposed signal is present, reproducible, clinically meaningful, and worthy of broader investigation.
Phase I — Retrospective Cohort Identification
The first phase could begin with retrospective chart review. Patients with recurrent pneumonia, recurrent bronchitis, persistent dyspnea, antibiotic-refractory respiratory illness, or repeated cardiopulmonary presentations could be identified, especially when chest imaging was negative, discordant, nonspecific, or not clearly explanatory.
The goal of this phase would not be to prove the hypothesis. The goal would be to determine whether a measurable signal exists.
Potential variables could include recurrent pneumonia or bronchitis diagnoses, number of antibiotic courses, imaging findings, positional symptoms, unexplained dyspnea, right-sided thoracic pain, repeat ED visits, hospitalizations, specialty referrals, and documented lack of durable response to standard infectious treatment.
Phase II — Multidisciplinary Case Review
The second phase could involve structured multidisciplinary case review. Internal medicine, pulmonology, cardiology, infectious disease, radiology, vascular medicine, emergency medicine, and diagnostic safety contributors could review selected cases to identify recurring patterns.
This phase would ask whether the cases show recognizable features that single-specialty pathways may have missed, including subtle imaging clues, physiologic mismatch, repeated negative workups, positional symptom patterns, antibiotic nonresponse, or evidence that the diagnostic pathway failed to converge.
The goal would be to refine the phenotype before attempting formal prospective validation.
Phase III — Prospective Phenotype Validation
The third phase could involve prospective cohort development. Patients meeting predefined criteria could undergo standardized evaluation, including careful symptom chronology, positional assessment, antibiotic response history, imaging review, cardiopulmonary evaluation, and structured documentation of prior diagnostic pathways.
This phase would test whether the candidate subgroup can be identified prospectively rather than only retrospectively. It would also help determine which clinical features most reliably predict membership in the subgroup.
Phase IV — Physiology-Matched Diagnostic Evaluation
The fourth phase could compare diagnostic yield between standard pathways and targeted physiology-matched evaluation in selected patients.
Depending on the candidate phenotype and the findings from earlier phases of investigation, this evaluation may include venous-phase CT, MR venography, cardiac MRI, targeted echocardiography, dynamic thoracic imaging, thoracic inlet evaluation, or other modalities designed to assess physiology rather than simply exclude acute infectious or arterial disease.
The goal would be to determine whether matching diagnostic evaluation to the suspected physiology improves diagnostic yield, reduces uncertainty, or changes management.
Phase V — Multicenter Registry or Collaborative Observational Study
If a signal is identified, the fifth phase could expand into multicenter collaboration. PAJR-associated cases, institutional partners, complex diagnostic programs, Long COVID clinics, pulmonary clinics, emergency departments, and cardiology or vascular medicine collaborators could contribute to a registry or multicenter observational study.
This phase would evaluate prevalence, reproducibility, diagnostic pathways, management changes, outcomes, and whether the subgroup appears across multiple clinical populations rather than within a single diagnostic label.
A multicenter structure would also allow the project to move beyond anecdote and determine whether the proposed diagnostic blind spot is rare, clinically meaningful, or potentially practice-changing.
Potential Clinical Impact
If this subgroup does not exist, that would still be useful. It would clarify the boundary of the hypothesis and prevent overextension.
If it does exist, even in a small but clinically meaningful subset, the implications could be substantial. It could affect diagnostic reasoning, imaging pathways, antibiotic stewardship, emergency department utilization, hospital readmissions, complex case review, Long COVID evaluation, HFpEF mimic recognition, and the handling of patients labeled functional or medically unexplained.
Because the burden of diagnostic delay is cumulative, even modest improvements in recognition could meaningfully reduce unnecessary antibiotic exposure, repeated investigations, fragmented specialty care, and prolonged uncertainty for affected patients.
The point is not to replace existing diagnostic categories with a new one. The point is to ask whether some patients are being sorted into familiar categories because those are the only categories current pathways are prepared to see.
Why This Question Matters
Medical progress has often occurred not by discovering entirely new diseases, but by recognizing that seemingly unrelated patients shared an underlying biology that had previously gone unnoticed.
This proposal asks whether recurrent pneumonia-like illness, unexplained dyspnea, recurrent bronchitis, selected Long COVID presentations, HFpEF-like syndromes, complex diagnostic cases, and other persistent cardiopulmonary conditions may contain such a subgroup.
If one does exist, even in a relatively small subset, the implications extend beyond pneumonia. They extend to diagnostic reasoning itself.
Invitation for Collaboration
I have spent the past year thinking about this question, and the more I have worked on it, the less it has felt like a single-author manuscript.
Whether the hypothesis ultimately survives exactly as framed is, in many ways, secondary. What seems worth preserving is the question itself.
If no such subgroup exists, establishing that boundary would still represent a meaningful contribution. If a clinically meaningful subgroup does exist, however, the implications could extend into diagnostic reasoning, imaging pathways, antibiotic stewardship, cardiopulmonary medicine, complex diagnostic care, and multidisciplinary education.
My hope is not to convince a group that the answer has already been found. My hope is to assemble a group willing to determine whether the question deserves to change the way we investigate these patients.
Whether the hypothesis is ultimately confirmed, refined, or disproven, a rigorous multidisciplinary investigation would still represent progress. If it reveals an overlooked physiologic subgroup, however, the implications could extend well beyond recurrent pneumonia and inform the broader architecture of diagnostic reasoning across clinical medicine.
Ultimately, the value of this proposal will not depend on whether its central hypothesis is confirmed exactly as written. Its value will depend on whether it helps identify better questions, more informative diagnostic pathways, and previously unrecognized physiologic relationships that improve patient care.
If there is interest, I would welcome the opportunity to help organize a multidisciplinary PAJR working group to refine the framework, challenge its assumptions, identify appropriate collaborators, and determine whether this concept merits formal investigation.
[10:26 AM, 6/13/2026] hu2: We train our students to first strip all gathered data off their PII. Also we teach them to collect the data in a manner that PIIs are avoided even while clicking them onto the phone
[10:28 AM, 6/13/2026] hu2: Gemini on the google web browser also has your dynamic daily updated Google profile that enables it to provide it's inputs tailored to your updated profile
[10:44 AM, 6/13/2026] hu2: Thanks for sharing your well framed clinical complexity thesis on optimizing pneumonia uncertainty to optimise antibiotic usage and we have worked on similar lines here in the last few years when we realised not just clear film pneumonia but even pneumonic consolidations in chest X-rays and Hrct chests were not really infectious pneumonia but were largely closed by us as heart failure with preserved ejection fraction given the ancillary findings of metabolic syn in the same patients.
The problem of radiology misinterpreted also surprisingly took one COVID epidemic to make this clearer to current science!
[10:49 AM, 6/13/2026] hu2: I guess we are moving toward an Orwellian ambient AI utopia where all our current offline 3D interactions as portrayed in @hu7's video here: https://youtu.be/xvE5b8Xk3vM?si=lsnU2f58BQ9OU0cS
will be made 2D for optimized AI processing toward tech enhanced learning.
[11:00 AM, 6/13/2026] hu15: Ambient AI is a dystopia, as perfectly described by Orwell originally.
[12:16 PM, 6/13/2026] hu27: On it sir!
[1:10 PM, 6/13/2026] hu7: Ai is just a knowledge partner with speed and errors. A good person to have on the team. 😊
[1:10 PM, 6/13/2026] hu7: Person team mate
[1:12 PM, 6/13/2026] hu7: 2 primates using same tool. A gun
😅
[1:13 PM, 6/13/2026] hu7: I mean to say, right use is important by understanding the pros and cons.
[1:22 PM, 6/13/2026] hu7: 2 photos
Both pics are extreme but both ☯ happen in a range.
[1:26 PM, 6/13/2026] hu15: The entity holding the gun has to be sentinent. There is no evidence till now that any of the models are sentinent. Irrespective of what Anthropic claims
[1:27 PM, 6/13/2026] hu7: Yes. Entity
[1:30 PM, 6/13/2026] hu27: https://g.co/gemini/share/0c002b88d2d9
[1:33 PM, 6/13/2026] hu27: Since I’m in posted in OG rn, I gave my first try here. Overall a great learning experience but I intentionally didn’t write negative history here to check whether AI asks me or not. And it skipped. Since this patient wants to undergo tubectomy, a more detailed format is usually taught to us conventionally.
[1:39 PM, 6/13/2026] hu27: Post duty, I’ll try with Gemini live by scanning my mom’s hand/physical examination since she’s been having some complains relevant to vitamin deficiencies lately.
